POPULARITY
Categories
151 episodes with hmo
73 episodes with hmo
64 episodes with hmo
28 episodes with hmo
26 episodes with hmo
51 episodes with hmo
31 episodes with hmo
26 episodes with hmo
14 episodes with hmo
21 episodes with hmo
280 episodes with hmo
25 episodes with hmo
18 episodes with hmo
10 episodes with hmo
16 episodes with hmo
7 episodes with hmo
8 episodes with hmo
15 episodes with hmo
19 episodes with hmo
7 episodes with hmo
17 episodes with hmo
13 episodes with hmo
12 episodes with hmo
11 episodes with hmo
6 episodes with hmo
7 episodes with hmo
4 episodes with hmo
5 episodes with hmo
13 episodes with hmo
4 episodes with hmo
12 episodes with hmo
80 episodes with hmo
78 episodes with hmo
2 episodes with hmo
4 episodes with hmo
5 episodes with hmo
2 episodes with hmo
4 episodes with hmo
4 episodes with hmo
8 episodes with hmo
4 episodes with hmo
3 episodes with hmo
3 episodes with hmo
12 episodes with hmo
4 episodes with hmo
4 episodes with hmo
4 episodes with hmo
6 episodes with hmo
61 episodes with hmo
5 episodes with hmo
3 episodes with hmo
6 episodes with hmo
3 episodes with hmo
4 episodes with hmo
Health Insurance is Rigged & Controlled by the Big Companies w/ Donvan Ryckis of Ethos Benefits - AZ TRT S06 EP10 (272) 6-15-2025 What We Learned This Week Health Insurance is primarily run by the Big 4 - BUCA: Blue Cross United Healthcare, CIGNA, Aetna To Insurance Co's – Premium = Revenue, and they are not going lower profits, so no incentive to lower costs Health insurance employer group plans can be broken down into 4 Parts Network PPO is what people typically think of when they think of health insurance There have been revisions to the Healthcare Act passed in 2021 Guest: Donovan Ryckis, Ethos Benefits https://ethosbenefits.com/ https://ethosbenefits.com/documentary/ https://businessofbenefitspodcast.com/ Our Ethos is Simple: Fiduciary First. Act in the best interest of those we serve—no matter the cost. ‘Ethos' represents the guiding principle, character, or spirit of a person or organization. It's the ‘why' that drives decision-making and fuel's purpose. Our Ethos is deeply rooted in the story of our Founder, Donovan Ryckis. Over a decade ago, Donovan, a fiduciary Series 65 securities advisor specializing in retirement and pension planning, was approached by a client facing a dire situation. The client's publicly traded broker claimed there was no solution for a staggering 37.5% health insurance renewal increase—a cost that threatened the business and its employees. With no prior experience in health insurance markets but guided by his unwavering fiduciary principles, Donovan took on the challenge. The result? He mitigated the risk entirely, delivering a solution 12% below the current rate. This allowed the business to thrive and ensured hundreds of employees wouldn't have to choose between basic necessities and skyrocketing health premiums. That moment sparked a revelation. The fraud, waste, and abuse Donovan had fought in retirement planning paled in comparison to the challenges in healthcare. He saw an opportunity to bring transparency and fiduciary principles to an industry in desperate need of change. Donovan pivoted his career, becoming one of the first fee-based health insurance advisors in the nation. By removing all conflicts of interest in broker compensation, he laid the foundation for what is now the leading innovative employee benefits agency in the country, delivering higher quality care at a significantly lower cost to employers nationwide. Notes: Ethos Benefits deals with employee benefits, with a primary focus on group health insurance Per Donovan ‘Employee benefits are rigged' Insurance company premium equals revenue. There is no incentive to lower cost, as it would lower profits. ACA Obamacare passed in 2010, and it capped profits for insurance companies at 20% Insurance Co's are working to expand their pool to make more profit Health Insurance guarantees inflation keeps going up, so family of 4 could spend 35K a year For a business, healthcare cost and employee benefits are a top 3 P&L expense Ethos strategies can create a 30 to 40% reduction on premium impact to lower costs for a business The HQ is in Florida, but they are a virtual office with agents and clients nationwide Healthcare finance and delivery + Improving employee benefits Seg 1 Donovan's bio, he was a financial advisor with a Series 65 license before he got into health insurance. Around 2014 he moved into health insurance seeing an opportunity for better service. Typically you see agents who are working for the health insurance company and not really working for the employer companies they are selling to. Health insurance is primarily run by the Big 4 – BUCA: Blue Cross United Healthcare, CIGNA, Aetna. Health insurance employer group plans can be broken down into 4 Parts: 1. TPA or third-party administrator 2. Network PPO or HMO 3. Pharmacy benefit RX 4. Insurance that covers the caps the limits on the stop loss PPO is your primary network and open on using referrals HMO is a non-preferred network typically has less offerings and tight on referrals Ethos Benefits helps employers to break up the four parts of a group plan and customize Network PPO is what people typically think of when they think of health insurance. Network and the Big 4 health companies have a tighter deal with doctors and contract prices. A lot is pre-negotiated with a set of rates, which is the point of a PPO. This is where you get larger claims and they run in the system of healthcare. Seg 2 Pay more for healthcare in the U.S. than the rest of the world The biggest pharmaceutical companies are in the US Pharmaceutical companies in flight prices, and also set the prices They make money through spread pricing Employers can actually pick up their own Pharma benefit and get the rebates that the big health insurance companies are not giving them Healthcare system is a rigged game The fraud waste and abuse extremely high in health 401(k) and retirement benefit industry is actually tighter with more disclosure than the healthcare industry Regulated better since the creation of the Securities Act in the 1930s and updates that ran through the 1970s and beyond with things like ERISA There have been revisions to the healthcare act passed in 2021 - started in Jan.2022 Actions had 3 disclosures: · Brokers comp and bonus · Data with gag, clauses, and full access to data upon request · Benchmarking for drug cost Further Notes via Google: The revisions you are likely referring to are part of the Consolidated Appropriations Act of 2021 (CAA). While the CAA was passed in late 2020, many of its provisions, including those related to transparency in healthcare, became effective on January 1, 2022. The three key areas of disclosure you mentioned are directly addressed within these regulations: 1. Broker's Compensation and Bonuses: The CAA amends ERISA Section 408(b)(2) and requires service providers, including brokers, to disclose specific information to group health plan fiduciaries. 2. Data Transparency (Gag Clauses and Full Access to Data): The CAA prohibits gag clauses, which prevent plans from providing access to their data. It also requires health insurance carriers to attest annually to their compliance with this prohibition. Moreover, the Health DATA Act, a proposed bill, would further reinforce the right of employers to access their data and hold service providers accountable for non-compliance. 3. Benchmarking for Drug Costs: The CAA includes provisions regarding pharmacy benefit and drug cost reporting, which aims to provide greater transparency and potentially lead to better benchmarking of drug costs. The Build Back Better Act, a separate piece of legislation, also included provisions for Medicare to negotiate drug prices, further impacting drug costs and potential benchmarking. These revisions aim to increase transparency in healthcare pricing and empower consumers and employers to make more informed decisions about their healthcare coverage. Seg 3 Ethos works with Employers to create business plans usually with a 3 to 5 year time horizon. The goal is long-term to lower healthcare cost. Example would be a company with 100 employees with 50 to 80% of them on the health plan (does not include dependents). Ethos wants to keep the demands of a company low, easy transition. Ethos handles employee Qs and healthcare navigation. Ethos is full service. Risk handled 1 of 4 ways - Reduce, avoid, retain, transfer - Transfer to insurance Broker wants to transfer risk Company can control costs Careful not to have too much disruption with a switch to a new company Ex - start with pharmacy part NDC National Drug Code Run report vs costs Pharmacy benefit mgr Pre packaged health plan Gets co approved pharmacy benefit Save 5 - 15% on costs (30%) Separate - parts of group plan Seg 4 Brokers comp - incentives from big insurance companies Opening move - edit pharmacy benefit piece State by state - regulators and rules Employers / employees Know the network and PPO Nationwide covers insurance part – Stop-loss Insurance 30-40 major stop loss companies Ex: Allstate Met Life Sun Life Stop-loss insurance for group health plans acts as a financial safety net for self-funded employers, protecting them from large, unpredictable medical claims. It is a form of additional insurance. Healthcare risk is incredibly predictable on group basis Overall predictable w stats, actuarial analysis Gag clauses look at dataset from current carrier Prescription database sets 3rd party admin are less of a concern, lots of claims Average of 18 claims per employee per year, includes dependents Data - review AI Claims analytics software AI claims analytics software is transforming how insurance companies handle claims by leveraging artificial intelligence and machine learning to analyze data, automate tasks, and improve decision-making. 30 - 40% reduction in premium w Ethos Further Notes via Google: Group Medical Plans Breakdown of the common components of a comprehensive employer group health plan, particularly within the context of a self-funded model. Here's a more detailed explanation of each part: 1. TPA (Third-Party Administrator): A TPA is a company that provides administrative services for self-funded health plans. This includes processing claims, handling enrollment, and managing other administrative tasks that would typically be done by an insurance company. 2. Network (PPO or HMO): This refers to the group of doctors, hospitals, and other healthcare providers that the health plan contracts with to provide services to its members. The network defines where employees can go to receive care and often dictates the level of coverage they will receive (e.g., in-network vs. out-of-network benefits). · PPO (Preferred Provider Organization): Offers more flexibility, allowing members to see out-of-network providers, though with higher out-of-pocket costs. · HMO (Health Maintenance Organization): Typically requires members to stay within the network for covered services, except in emergencies. Pharmacy Benefit (RX): This component manages the prescription drug coverage for the plan. It includes negotiating drug prices, processing claims for prescriptions, and managing the plan's formulary (list of covered drugs). Stop-Loss Insurance: This is a crucial element for self-funded employers. It protects the employer from catastrophic claim costs. If an individual employee or the entire group's claims exceed a certain threshold (the "attachment point"), the stop-loss insurance kicks in to cover the excess costs, limiting the employer's financial liability. Additional Considerations: · Data Access: Self-funded plans often provide employers with greater access to claims data, which can be used to analyze healthcare costs, identify trends, and implement strategies to improve employee health and manage costs. · Benchmarking: Employers can use claims data and industry benchmarks to compare their plan's performance to similar organizations and negotiate better rates with providers and other vendors. · Wellness Programs: Some employers offer wellness programs to encourage employees to adopt healthy behaviors and potentially reduce healthcare costs. · Essential Health Benefits (ACA Compliance): Group health plans must comply with the Affordable Care Act (ACA), which requires them to cover a list of essential health benefits, such as outpatient care, emergency services, hospitalization, and prescription drugs. · Other Benefits: Group plans can also include other benefits, such as dental, vision, life insurance, and long- and short-term disability insurance. Understanding these different parts is essential for employers to effectively manage their group health plan, control costs, and provide valuable benefits to their employees. Investing Shows: https://brt-show.libsyn.com/category/Investing-Stocks-Bonds-Retirement ‘Best Of' Topic: https://brt-show.libsyn.com/category/Best+of+BRT Thanks for Listening. Please Subscribe to the AZ TRT Podcast. AZ Tech Roundtable 2.0 with Matt Battaglia The show where Entrepreneurs, Top Executives, Founders, and Investors come to share insights about the future of business. AZ TRT 2.0 looks at the new trends in business, & how classic industries are evolving. Common Topics Discussed: Startups, Founders, Funds & Venture Capital, Business, Entrepreneurship, Biotech, Blockchain / Crypto, Executive Comp, Investing, Stocks, Real Estate + Alternative Investments, and more… AZ TRT Podcast Home Page: http://aztrtshow.com/ ‘Best Of' AZ TRT Podcast: Click Here Podcast on Google: Click Here Podcast on Spotify: Click Here More Info: https://www.economicknight.com/azpodcast/ KFNX Info: https://1100kfnx.com/weekend-featured-shows/ Disclaimer: The views and opinions expressed in this program are those of the Hosts, Guests and Speakers, and do not necessarily reflect the views or positions of any entities they represent (or affiliates, members, managers, employees or partners), or any Station, Podcast Platform, Website or Social Media that this show may air on. All information provided is for educational and entertainment purposes. Nothing said on this program should be considered advice or recommendations in: business, legal, real estate, crypto, tax accounting, investment, etc. Always seek the advice of a professional in all business ventures, including but not limited to: investments, tax, loans, legal, accounting, real estate, crypto, contracts, sales, marketing, other business arrangements, etc.
In this episode of the Scottish Property Podcast, Nick and Steven sit down with Angus Johnston, founder of LetUs, a Glasgow-based letting agency specialising in HMOs. Angus shares his fascinating journey from aspiring investment banker and full-time wedding singer to building a business managing over 120 properties – with a strong focus on the student HMO market in Glasgow.Episode Highlights:
In this special solo episode, Neil Gibb shares a powerful preview from his upcoming book Micro-Apartment Millions – diving into a chapter that could reshape the way you think about property investing forever. Neil explains how commercial valuation methods used by institutional investors (think family offices and super funds) differ massively from typical retail property thinking. If you've ever been stuck chasing capital growth, waiting for the market to do the heavy lifting – this is the wake-up call you didn't know you needed. You'll learn: Why your HMO isn't “just another house” The simple valuation formula that builds millions in equity – fast How yield, not suburb growth, drives serious portfolio value Why institutional players only work with scalable, professional operators How you (as a retail investor) can align yourself with commercial-grade opportunities
In this week's episode of The Property Rebel, Arsh Ellahi tackles one of the most hotly debated questions in the UK property investment community. With interest rates normalising between 5-6% and cash flow margins tightening, many investors are questioning whether buy-to-let still makes financial sense. What You'll Learn: Real-world cash flow analysis - Breaking down the numbers on a £100k property investment The true cost of financial freedom - Why you might need £300k to generate £3k monthly income Buy-to-let vs HMO strategies - Comparing cash flow, management complexity, and exit strategies Capital appreciation case study - How a 25-year property investment delivered over £100k in gains Strategic decision-making - Choosing the right investment approach for your goals Key Insights: Drawing from over 24 years of property investment experience, Arsh shares a compelling case study of a Wolverhampton property purchased in 2000 for £75k, now valued at £180k, while generating steady rental income throughout. Join the Property Investor App WhatsApp Channel: bit.ly/PIAWhats Book Your 1 Hour Call with Arsh here: http://bit.ly/1HourPropertyCoach Wanna connect with Arsh? Click this link: www.arshellahi.com/contact Want to know more about the Property Rebel? Head over to Arsh's Youtube Channel. Where you can find lots more quality content and information. Click To Subscribe Have you heard about Arsh's app the Property Investor? You can download it directly to your mobile by clicking the links below: Apple Devices: Download Here Android Devices: Download Here Or Visit the website by clicking HERE Thank you for listening! #propertyrebel
#221Some people in UK property prefer to buy flats. Some people prefer houses.Where do your preferences lie? Is your preference the same now as a few years ago? This episode takes you through the advantages and disadvantages of both property types to bring your knowledge on this topic up to date.By the end of the show, you'll have a better idea of where you stand in 2025: Flats or Houses.Overview of seven advantages of houses over flats:Greater control as a freeholder versus leaseholder.Increased security and privacy.More development potential (extensions, lofts, HMOs, or conversion to flats!)Longer tenancy periods (attracting families who stay longer).Potential for capital growth, especially for certain house types and locations.More exit strategies and easier resale due to broader market demand.Summary of flats' disadvantages (e.g. lease issues, service charges, noise, cladding).Overview of seven advantages of flats over houses:Lower entry cost, making it easier to get started in property investment.Potentially higher yields based on lower purchase prices.Flats may currently be undervalued, creating possible buying opportunities.City centre locations, which attract short-term lets and service accommodation.Lower maintenance costs and more predictable expenses (thanks to service charges).Less active management required, often attracting expats and remote investors.Summary of houses' disadvantages (higher costs, more active management required).Analysis of regional price gaps and factors such as cladding, COVID, and city living trends.Reminder that choosing between houses and flats depends on investment goals and location-specific research.Mention of other strategies and market opportunities, like lease extensions and commercial auctions.Conclusion: Investors don't have to choose one or the other—consider diversification, understand local markets, and aim for a balance between cash flow and capital growth.I'd Like Help With Setting My GoalsExclusive Property Engine discounts (Code: EXPAT)Starter package: 30 day trial instead of the usual 14Pro package 30 day trial, then 3 months 1/2 price Ultimate package launches that will be the same, 1/2 price for 3 monthsLeave a reviewJoin our WhatsApp group / access 37 Question Due Diligence Checklist / 23 Step Guide to Buying Property at AuctionInstagramKeywords: UK property investment, flats vs houses, leasehold vs freehold, property control, property privacy, development potential, tenant turnover, rental yields, capital growth, exit strategies, property maintenance costs, city centre property, service charges, ground rent, cladding issues, property management, remote property investing, expat investors, HMO properties, property appreciation, property location, property diversification, cash flow, property auctions, short lease extensions, property market trends, investment goals, off-plan developments, new build flats, property value gap
In this week's episode, I'm joined by Ryan Etchells from Together. Ryan is the Chief Commercial Officer at Together, one of the UK's leading specialist lenders. With a huge lending book, a strong appetite for HMOs, and years of experience in the sector, they really know their stuff.What you'll discover today is that Ryan brings a unique and valuable perspective from the lender's side of the table. He shares some brilliant insights—and, more importantly, practical advice—that could help you strengthen your applications and build better relationships with lenders.So, if you're finding it tough to get the results you want from a lender, or if scaling your property business has hit a financing wall, then this episode is one you don't want to miss!Topics covered in this episode:03:13 - Understanding Together Finance and Its Unique Approach07:43 - Current Trends in HMO Lending and Market Dynamics12:45 - The Importance of Relationships with Lenders17:04 - Defining a Good Deal in the HMO Market34:54 - Case Study: A Unique HMO Investment Story-Did you find this episode useful? Please leave us a quick review on Apple Podcasts or Spotify!Got any questions? Join The HMO Community on Facebook!Connect with me on Instagram or Linkedin for daily HMO tips and advice! If you want to join my 1-2-1 mentoring program, you can enquire here. Feeling overwhelmed and don't know where to start? Join The HMO Roadmap on a Premium plan and get all-access to our award-winning library of 400+ resources to help you start, scale and systemise your HMO business. Get instant access here.
I det här avsnittet pratar vi om refinansiering – vad du behöver tänka på, vanliga fallgropar och vilka steg du bör följa för att göra det på rätt sätt.Vill du prova på vår mastermind?Vi erbjuder ett prova-på-tillfälle där du får känna på energin!Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://us6.campaign-archive.com/?u=5b6248a33b48fa474db5c8976&id=57a85f086eTack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
In this week's episode of the UFD Podcast, I'm joined by Katie Harvey co-director at Haines Homes and all-around powerhouse. Katie's not only been smashing it with her rent-to-rent HMO portfolio in Oxford, but she's also launched a brand new business called Breathe, focused on helping entrepreneurs avoid burnout and actually enjoy the life they're building. Katie and I dive deep into how she turned her business around by ditching the "scale-at-all-costs" mentality and zeroing in on profit margins. We dive into the power of financial planning, specifically how using a 12-month forecast helped Katie feel confident enough to leave her job as an electrical contractor, fully commit to entrepreneurship and create a life she's actually excited to live. Katie also introduces her new venture, Breathe, which is all about helping other entrepreneurs avoid burnout through intentional lifestyle design. It's a refreshing take on business - one that puts wellbeing and balance at the forefront. We chat about what it's like running a business with family, including the dynamics, the boundaries, and the benefits of working with people you trust. And finally, we explore how finding your “sweet spot” in business - that place where things run well without being overwhelming - can make all the difference. It's a proper behind-the-scenes look at how we've made big shifts, both in the business and in life - and why it's paying off in more ways than one. Give it a listen, and as always, let me know your biggest takeaways. You can connect with Katie across socials via her links below: https://www.instagram.com/haineshomes_/ https://www.linkedin.com/in/katie-harvey-097571195/ UFD RESOURCES:
#220This episode explores how Matt, a Singapore-based expat, got started in UK property. You'll see the steps he took, the challenges he faced and lessons he learned. You'll get to see the detail behind the three deals he's done so far: two buy to lets and one HMO. During the episode, we discuss:· Choosing Property over Stocks: Matt found stocks and shares less predictable and exciting, preferring the tangible, long-term benefits of UK property.· Partnership with his builder Brother-in-law in the UK: leveraging complementary skills.· Setting Up a Joint Venture: Challenges around residency, lender requirements, and shareholder splits.· Company Structure and Lender Preferences: Limiting Matt's share to 19% (under the 20% threshold for mortgages) maximized their mortgage options.· Shareholder Agreement: They established a basic shareholder agreement (even using ChatGPT!) and took tax/accountancy advice to protect both sides and cover contingencies.· 1st Deal—Buy-to-Let in Birmingham: Their debut property was a terraced house fully renovated by the brother-in-law—bought with cash, got rented quickly, but had modest ROI (~8%).· 2nd Deal— Buy-to-Let: Boughton same street, similar renovation, lower purchase price, higher ROI (~20%).· 3ed Deal— 5-bed HMO Project: Purchased via pre-auction offer, converted with all en-suites, targeting professional tenants.· Navigating HMO Regulations: Matt emphasized the importance of understanding fire, safety, and local council HMO rules, leveraging an architect for compliance.· Finance and Valuation Strategies: The HMO refinance options included commercial, hybrid, and bricks-and-mortar valuations—each affecting how much capital could be recycled.· ROCE Comparison of Single Let Vs Hmo: Despite their HMO generating higher monthly cash flow, their standard single lets delivered a much healthier ROCE (Return on Capital Employed) of around 20%, while the HMO project achieved just under 9% ROCE, · Challenges as an Expat: Communication issues (time zones, local contacts), UK call centre frustrations.· Lessons Learned: the dangers of overanalyzing, the value of taking early action, and being flexible with deal expectations to maintain momentum.I'd Like Help With Setting My GoalsExclusive Property Engine discounts (Code: EXPAT)Starter package: 30 day trial instead of the usual 14Pro package 30 day trial, then 3 months 1/2 price Ultimate package launches that will be the same, 1/2 price for 3 monthsLeave a reviewJoin our WhatsApp group / access 37 Question Due Diligence Checklist / 23 Step Guide to Buying Property at AuctionInstagramKeywordsUK property investment, expat property investing, buy to let, HMO investment, joint venture property, property portfolio, Singapore expat, UK mortgages for expats, remote property investing, property partnership, limited company for property, shareholder agreement, property renovation, Birmingham propert
Struggling to Get Your HMO Business Off the Ground? You're Not Alone...In this episode, we're tackling some of the biggest challenges investors face when trying to grow their HMO businesses. If you're finding it hard to build momentum, if costs are rising, timelines are stretching, and the numbers just don't look as promising as you expected—this one's for you.I'll be breaking down the five most common strategic mistakes that I see time and time again, which could be holding you back from the success you're aiming for. More importantly, I'll be sharing practical solutions to help you overcome these challenges and move forward with clarity and confidence.Whether you're just starting out or looking to scale, don't miss this honest and insightful discussion designed to help you build the HMO business you really want—faster and more effectively.Topics covered in this episode:01:27 - The Five Strategic Mistakes in HMO Investing03:35 - Chasing Unicorn Deals11:17 - Underestimating Pre-Commencement Costs16:24 - Outsourcing Without Understanding19:47 - Not Playing the Numbers Game22:16 - Wasting Visibility Opportunities-Did you find this episode useful? Please leave us a quick review on Apple Podcasts or Spotify!Got any questions? Join The HMO Community on Facebook!Connect with me on Instagram or Linkedin for daily HMO tips and advice! If you want to join my 1-2-1 mentoring program, you can enquire here. Feeling overwhelmed and don't know where to start? Join The HMO Roadmap on a Premium plan and get all-access to our award-winning library of 400+ resources to help you start, scale and systemise your HMO business. Get instant access here.
Add the best superfood for immunity to your diet today! Discover the countless health benefits of colostrum for your immune system, gut health, and more. Learn about the benefits of colostrum for adults and aging populations. It's not just for babies!0:00 Introduction: The best superfood for immunity 0:44 What is colostrum? 1:12 Colostrum benefits 3:33 Colostrum for adults3:43 Colostrum and gut health4:01 More colostrum uses 4:54 How to take colostrumColostrum is produced in the first 24 to 72 hours after birth. It's golden in color and rich in essential probiotics, including L. reuteri. It's significantly more immune-building than regular milk and even contains stem cells. Colostrum also contains an important prebiotic called HMO (human milk oligosaccharides) that feeds the probiotics found in breast milk. Colostrum contains cholesterol and omega-3 fats, vital for brain health, and important hormones like oxytocin and cortisol.Many infants are fed infant formula, which is essentially ultra-processed food calories. Most infant formulas are made of low-quality ingredients such as maltodextrin and soy, and they lack the immune benefits and probiotics of breast milk. Children who were fed infant formula are more predisposed to allergies, asthma, skin problems, obesity, cognitive delays, and other health problems. If you didn't get colostrum as a baby, there are still many benefits of colostrum for adults. You can take colostrum in supplement form. Colostrum is beneficial for gut health and can help fix a leaky gut or gut damage. It can help lower inflammation, increase good microbes, and decrease pathogens. Colostrum has powerful benefits for respiratory problems such as allergies and asthma. It can also help an overactive immune system and many autoimmune conditions. Colostrum helps support the thymus glands as you age and is very beneficial for age-related problems such as muscle loss, wrinkles, macular degeneration, and arthritis. It can even help with long COVID, Hashimoto's, autism, and Lyme disease. Colostrum is heat-sensitive, so look for a freeze-dried supplement!Dr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the author of the best-selling book The Healthy Keto Plan, and is the Director of Dr. Berg Nutritionals. He no longer practices, but focuses on health education through social media.
This month, Mark is joined by Matt Dolman, the Mindful Landlord who shares with us his journey of building a portfolio of 14 properties with 6 figure profits. Matt is in his third year on Property Entrepreneur and his second on Adam Goff's Mastermind. He has built his portfolio using property sourcer's to help find the properties, assist with any refurbishments and with the letting. Matt shares his experiences from buying his first flat to his latest two deals which are with a care provider on a 5 year lease. Whilst it is highly lucrative, it hasn't been without its challenges so listen to find out more! The numbers on his latest two deals are: 5 bed HMO in Salford, all en suite: Purchase Price: £250,000 Light refurb: £27,000 All in with costs: £30,000 Lease payment £2750 pm, £33,000 pa Return on cash employed: 11% 6 bed HMO in Wigan: Purchase Price: £120,000 Refurb: £100,000 All in with costs: £250,000 Lease payment £2340 pm, £28,080 pa Return on cash employed: 11% Want to contact Mark or his guests? www.thepropertybrokerage.co.uk mark@thepropertybrokerage.co.uk Matt Dolman Matt is setting up a program to help others build a Property Portfolio using sourcing agents and his power team, if it's of interest, you can reach him on: Email - matt@themindfullandlord.co.uk Instagram - #themindfullandlord This isn't a theory. It's a proven Blueprint.
JCO Editorial Fellow Dr. Lauren Shih and JCO Associate Editor Dr. Stephanie Wheeler discuss the ASCO 25 Simultaneous Publication paper "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Transcript The guest on this podcast episode has no disclosures to declare. Dr. Lauren Shih: Hello, and welcome to our 2025 ASCO annual meeting series where we cover some of the top JCO papers published simultaneously with their abstract presentations at this year's meeting. I'm your host, Dr. Lauren Shih, JCO editorial fellow, and I'm joined by JCO Associate Editor Dr. Stephanie Wheeler to discuss the Journal of Clinical Oncology article and abstract presentation "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." Let's start with the relevance of the article. Dr. Wheeler, can you explain this to our listeners? Dr. Stephanie Wheeler: Thank you so much. Let's get right into it. So this article is really about understanding different types of Medicare plans and what we should expect to see in terms of their use of low-value treatments for cancer patients. So, as Medicare really is focused on trying to limit the use of low-value cancer treatments, we really need to better understand the drivers of variability. So we know that many cancer patients have multiple treatment options available to them. We also know that the vast majority of older adults beyond age 65 are insured by Medicare, and about half of them are on Medicare Advantage plans, which are serviced by private insurance. And private insurance companies in this case are receiving capitated payments for Medicare beneficiaries to manage their service utilization and reduce costs. So, with respect to Medicare Advantage versus the traditional fee-for-service Medicare, it's not really been known to what extent low-value treatments are differentially used by these types of plans for cancer patients. And so that was really the focus of this article. What the authors found is that across six different types of treatments, in general, the folks who were enrolled in Medicare Advantage plans had reduced use of low-value treatment. So that's a good sign for Medicare beneficiaries. And although the relative difference in that use was somewhat low, this translates to a significant number of Medicare enrollees across the country not receiving these low-value treatments. And of course, this translates to considerable savings at the society level. Dr. Lauren Shih: Are there any additional key results that we should review? Dr. Stephanie Wheeler: Yeah. So I'll tell you just a little bit more about the methods and also their findings. So they looked at six different low-value treatments, and this was in, again, 100% of national Medicare enrollees from 2015 through 2021. So the six low-value treatments that they examined were the use of G-CSFs among patients receiving low-risk chemotherapy and denosumab for those who had castration-sensitive prostate cancer. Then they also looked at four high-cost treatments, including using nab-paclitaxel instead of paclitaxel for patients with breast or lung cancer; second, adding bevacizumab to carboplatin plus paclitaxel for ovarian cancer; third, using brand-name drugs instead of generics when generics were available; and fourth, using biologics instead of biosimilars when biosimilars were available. And these are all, by the way, non-recommended treatments according to a variety of guidelines, including NCCN and ASCO's Choosing Wisely guidelines. So they used the Medicare claims data to examine use of these regimens. They also analyzed results by type of Medicare Advantage plan, whether people were enrolled in a health maintenance organization plan, or an HMO, or a preferred provider organization plan, or a PPO. They also looked at the largest Medicare Advantage insurers—including Aetna, Blue Cross Blue Shield, Cigna, Humana, and UnitedHealth—and limited their analyses to those that had complete encounter data. And what they found across the board is that the enrollees in Medicare Advantage plans generally had lower use of these low-value treatments. And the largest differences between Medicare Advantage and traditional Medicare plans were in the outcomes, including G-CSF use and using denosumab for castration-resistant prostate cancer, and then the combination of bevacizumab, carboplatin, and paclitaxel versus carboplatin and paclitaxel. And all of these had a change in use ranging from about 19% change to 24% change in use. This is significant as a field as we look at ways in which different plan organization can influence use of treatments, particularly given the excess cost of cancer care. This is something we really want to pay attention to. So I'd encourage folks to look more closely at the results by treatment type as well as the results by plan type to see a little bit more about what was going on across different plan types. Dr. Lauren Shih: Great. And are there any outstanding questions that need to be answered? Dr. Stephanie Wheeler: Yes, there always are, of course. I think the study has several strengths that are worth noting. First, they have 100% of Medicare enrollees, so there's national coverage there, which is, you know, quite outstanding. They also use an appropriate choice of analysis to help deal with some of the selection. So they use inverse probability of treatment weights, and they control for practice and county indicators to try to get some realistic adjustment for the selection that happens in terms of how patients are enrolled in different Medicare Advantage versus traditional fee-for-Medicare plans. These statistical approaches are a good idea, but they are limited by the observed variables that we can use for these kinds of adjustments. And so any unobserved—confounding or any unobserved factors that would influence selection in these plans aren't going to be captured well. So preferences, for example, that patients may have about different types of plans when they're insuring themselves and their families may not be captured. Second, the data that are used are only encounter data from those plans with complete records. That may mean that smaller Medicare Advantage insurers or those that don't have as comprehensive records are not included. So this may not be reflective of their practice patterns. And then third, of course, this only looked at six different low-value cancer treatments. It remains to be seen whether this kind of finding extends to other types of low-value cancer treatments, and that's an opportunity for future study. Finally, I would say that we don't exactly know why these patterns exist. It could be that Medicare Advantage plans have different approaches to prior authorization. They could have more in-house quality control and management to really understand, among their population for whom they're receiving Medicare Advantage payments, to really look at care quality and assess Choosing Wisely guidelines. We don't know exactly how that's playing out. And so we need additional data to really figure out what's working here and what are opportunities for future policy and payment innovations that can further reduce low-value care. Dr. Lauren Shih: Great. Thank you so much, Dr. Wheeler, for speaking to us about the JCO article, "Use of Low-Value Cancer Treatments in Medicare Advantage Versus Traditional Medicare." We really appreciate your insights. Dr. Stephanie Wheeler: Thanks for having me. Dr. Lauren Shih: Join us again for the latest simultaneous publications from the ASCO 2025 Annual Meeting. Please take a moment to rate, review, and subscribe to all ASCO podcast shows at asco.org/podcasts. Until then, enjoy the rest of ASCO 2025. The purpose of this podcast is to educate and to inform. This is not a substitute for professional medical care and is not intended for use in the diagnosis or treatment of individual conditions. Guests on this podcast express their own opinions, experience, and conclusions. Guest statements on the podcast do not express the opinions of ASCO. The mention of any product, service, organization, activity, or therapy should not be construed as an ASCO endorsement.
Dr. Robert Chandler, an esteemed orthopedic surgeon, graduated from Northwestern University Medical School in 1975, completed his residency at USC, and earned an MBA from USC in 1998. With 39 publications, he has significantly advanced orthopedic surgery through clinical trials and medical management. He has analyzed Pfizer's COVID-19 vaccine documents, raising concerns about development, data reporting, and adverse effects, particularly on women's health.Albert Benavides, a 25-year veteran in medical billing and revenue cycle management, is a renowned HMO claims auditor. Now a leading data analyst, he leverages his expertise as the world's foremost VAERS auditor, investigating critical vaccine data.Links:- VAERS Caught Covering Up Myocarditis In The "Follow-up" Data: https://welcometheeagle.substack.com/p/vaers-caught-covering-up-myocarditis- Closed VAERS Substack article "VAERS Caught Covering Up Myocarditis In The "Follow-up" Data (Part 2: and many other signals)": https://welcometheeagle.substack.com/cp/164393204- Robert W. Chandler, MD MBA on Substack: https://substack.com/@expermentalgenetherapy- Experimental Gene Therapy Substack: https://robertchandler.substack.com- Doctors for COVID Ethics: https://doctors4covidethics.org/- FOLLOW THE SILENCED film: https://followthesilenced.com- NCI Live Roundtable: Shawn Buckley, Dr. Chris Shoemaker, Dr. James Thorp, Dr. Robert Chandler: https://rumble.com/v5ygvat-nci-live-roundtable-shawn-buckley-dr.-chris-shoemaker-dr.-james-thorp-dr.-r.html- "Dr. Robert Chandler Exposes Batch-Based Injuries": https://rumble.com/v5emjk9-dr.-robert-chandler-exposes-batch-based-injuries.html- Exposing Hidden Covid-19 Vaccine Deaths in New Zealand with Albert Benavides | Part One: https://rumble.com/v6kyovv-the-purposeful-hiding-of-covid-19-vaccine-deaths-in-new-zealand-part-one.html?e9s=src_v1_ucp- Probing Deeper into Covid-19 Vaccine Data in New Zealand with Albert Benavides | Part Two: https://rumble.com/v6l1phg-the-purposeful-hiding-of-covid-19-vaccine-deaths-in-new-zealand-part-two.html?e9s=src_v1_ucp- Uncovering Patterns in New Zealand's Vaccine Death Data with Albert Benavides | Part Three: https://rumble.com/v6laeo1-the-purposeful-hiding-of-covid-19-vaccine-deaths-in-new-zealand-part-three.html?e9s=src_v1_ucp- Revealing the Full Scope of New Zealand's Vaccine Data Cover-Up with Albert Benavides | Part Four: https://rumble.com/v6lb2a1-the-purposeful-hiding-of-covid-19-vaccine-deaths-in-new-zealand-part-four.html?e9s=src_v1_ucp- Nanotechnology Found In ALL Vaccines | Andrew Bridgen, Tanya Lat & Sally Clark: https://rumble.com/v6t6rgz-nanotechnology-found-in-all-vaccines-andrew-bridgen-tanya-lat-and-sally-cla.html?e9s=src_v1_ucp- The Pfizer Papers: Pfizer's Crimes Against Humanity By The WarRoom/DailyClout Pfizer Documents Analysts & Naomi Wolf (Audiobook): https://www.audible.com.au/pd/The-Pfizer-Papers-Audiobook/B0DGVRC4PN?source_code=ASSGB149080119000H&share_location=pdp- VAERS Aware - https://www.vaersaware.com/new-zealand- Welcome The Eagle on Public Tableau - https://public.tableau.com/app/search/vizzes/welcome%20the%20eagle- Welcome The Eagle Substack - https://welcometheeagle.substack.com/- Closed VAERS profile - https://substack.com/@welcometheeagle- WelcomeTheEagle on Rumble - https://rumble.com/user/welcometheeagle- WelcomeTheEagle on X/Twitter: https://x.com/welcometheeagle--------FreeNZ:https://freenz.carrd.co
In this powerful interview, Abbas Pardhan (Managing Director of 10xRising, £100M+ portfolio) sits down with Rahim Bah—immigrant, ex-care leaver, and self-made property mogul—to Discuss about:- How he went from £0 to a 7-figure property empire (despite homelessness and job rejections)- Why he calls employment "the biggest killer drug" (and how to break free)- The moment he almost quit entrepreneurship (and the 6 deals that changed everything)- University vs. Mentorship: Why traditional education fails entrepreneurs- His first property deal (and how he convinced a skeptical landlord)Why I Quit My 9-5 & Built a Property Empire | Rahim Bah's Success Story interview with Abbas PardhanWhat You'll Learn in this video:How to start property investing with no money (rent-to-rent/HMO secrets)The psychological toll of entrepreneurship (and how to push through)Why most employees stay trapped (even when they hate their jobs)Negotiation tactics to secure deals without cashFollow Abbas Pardhan:Instagram - https://www.instagram.com/abbas_pardhan/?hl=enWebsite - www.10xrising.com
In this episode, we're talking about planning permission — and how you can use permitted development rights to get the most out of your property projects. I'll explain what you can do without needing full planning, and highlight the key caveats that can limit those rights.We'll also cover the types of projects that always require full planning permission, and the important considerations even when permission isn't technically needed.If planning has ever felt confusing or overwhelming, you're not alone — it is a complex part of property investment. But with nearly 20 years of experience, I'll help you make sense of it. Once you know the rules, it's far more manageable, and there are real opportunities to move faster and grow your property business.So if planning has been holding you back, this episode is for you. Topics covered in this episode:03:00 Understanding Permitted Development Rights12:01 Caveats and Restrictions in Permitted Development23:46 Navigating Conservation Areas and Planning Permissions31:11 Understanding Full Planning Permission Requirements39:36 Key Considerations Beyond Planning Permission-Did you find this episode useful? Please leave us a quick review on Apple Podcasts or Spotify!Got any questions? Join The HMO Community on Facebook!Connect with me on Instagram or Linkedin for daily HMO tips and advice! If you want to join my 1-2-1 mentoring program, you can enquire here. Feeling overwhelmed and don't know where to start? Join The HMO Roadmap on a Premium plan and get all-access to our award-winning library of 400+ resources to help you start, scale and systemise your HMO business. Get instant access here.
Following last week's episode on the RBA's recent rate drop, Neil Gibb dives deeper into the practical side of property investing — specifically equity: what it is, how to access it, and how savvy investors use it to scale their portfolios. In this solo episode, Neil unpacks what equity really means (without the fluff), how banks calculate how much you can access, and the pitfalls of getting caught in the cycle of never-ending debt. Whether you're sitting on unused equity in your home or looking to gear up for your next investment, this episode breaks it all down into simple, actionable insights. We cover: What equity actually is (and what it isn't) How much of your equity is actually accessible The difference between total equity and usable equity What a “cash out refinance” looks like in practice Why pulling equity doesn't trigger capital gains tax The role of serviceability in accessing new funds Why valuations differ for HMO properties What commercial valuations cost — and why they matter How experienced investors safely leverage growth without overextending Whether you're a seasoned investor or just starting out, understanding how to safely and effectively tap into equity can supercharge your property journey.
Nigel Farage Just Won Election? Reform UK Poll Surge –Starmer Slumps Farage #ReformUK #Starmer #UKPolitics
I det här avsnittet dyker vi ner i två populära investeringsstrategier i UK: Rent-to-Rent och Purchase Lease Options (PLO). Du får en tydlig jämförelse mellan strategierna hur de fungerar, vad du tjänar pengar på, och varför det är så viktigt att ha rätt avtal och struktur från början.Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-april-2025Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
I saw a course seller say, “This is how I treat my agent—I give them a nice bottle of wine.” What? £10 Sainsbury's Merlot? Even if it's a vintage Chablis… That's peasant behaviour. A £10 bottle? They can buy that in ONE hour of work. Have you ever seen someone go all-in for a slave wage bonus? No. Let me show you what I did— and how one move with one agent made me £250,000 (you can get the same RESULTS (MONEY) IF you follow THIS). I didn't give wine. I sent the firm manager's partner and 5 of her friends from Brighton to Edinburgh. They stayed at the 5-star Sheraton Grand, overlooking Edinburgh Castle. Infinity rooftop pool. Best spa in the country. Full red f*cking carpet. All expenses paid. They made memories. I got 16 HMO deals—all at 50% off. That's £250k in one year. That's ROI. That's real business. You think wine makes you top of mind? You think it makes a 9-5 prisoner WANT to make you rich? Delusion. Or you're hiding the real game behind your f*cking paywall. I bought memories. They sent me money. Or do this: Walk into the agency. View 10 similar properties. Find the flexible—or corrupt—agent (there's always one). Flash £500–£1,000 cash in a brown envelope and say: “Here's what I want: X, Y, Z. Can you help? Or know someone who can?” Forget wine. That's broke beginner strategy. You want results? You want loyalty? You want access? Be bold. Be best. Be DIFFERENT. That's something I learned from a billionaire. Thank you for watching/ listening to (Money School Minute) with Ryan OTTO
I saw a course seller say, “This is how I treat my agent—I give them a nice bottle of wine.” What? £10 Sainsbury's Merlot? Even if it's a vintage Chablis… That's peasant behaviour. A £10 bottle? They can buy that in ONE hour of work. Have you ever seen someone go all-in for a slave wage bonus? No. Let me show you what I did— and how one move with one agent made me £250,000 (you can get the same RESULTS (MONEY) IF you follow THIS). I didn't give wine. I sent the firm manager's partner and 5 of her friends from Brighton to Edinburgh. They stayed at the 5-star Sheraton Grand, overlooking Edinburgh Castle. Infinity rooftop pool. Best spa in the country. Full red f*cking carpet. All expenses paid. They made memories. I got 16 HMO deals—all at 50% off. That's £250k in one year. That's ROI. That's real business. You think wine makes you top of mind? You think it makes a 9-5 prisoner WANT to make you rich? Delusion. Or you're hiding the real game behind your f*cking paywall. I bought memories. They sent me money. Or do this: Walk into the agency. View 10 similar properties. Find the flexible—or corrupt—agent (there's always one). Flash £500–£1,000 cash in a brown envelope and say: “Here's what I want: X, Y, Z. Can you help? Or know someone who can?” Forget wine. That's broke beginner strategy. You want results? You want loyalty? You want access? Be bold. Be best. Be DIFFERENT. That's something I learned from a billionaire. Thank you for watching/ listening to (Money School Minute) with Ryan OTTO
He didn't have a massive bank balance or millionaire contacts. Just belief, hard work, and a willingness to take risks. Here's how Umesh left the 9–5 and built a full-time property business—including the hard lessons you won't find on social media. In This Episode (Part 1): We sit down with HMO and buy-to-let investor Umesh Kalra, owner of MoneyRow Properties, to uncover the real story behind leaving his 9–5 and going all in on property. He shares how he made the leap, the reality of his first deal, and why HMOs are still working in 2025 if you approach them properly. We cover: How Umesh transitioned from employment into full-time property His very first deal – what went right, and what he'd never do again The honest truth about running HMOs in today's market What separates a profitable HMO from a constant headache Key mistakes new investors make when trying to go full-time Whether you're planning your first deal or looking to replace your income through property, this episode delivers the reality behind making it happen.
The latest episode of the Charles Kelly Money Tips Podcast he explores the truth behind the buy-to-let market and exactly why he is getting out of buy-to-let after 30 years. Please like and subscribe - https://www.youtube.com/@charleskellymoneytipspodca9121 Brief history of the buy to Let market Watch video - https://youtu.be/Vy6NTf38uR8 My story of finding a rental property before BTL and pre-ASTs - It was worse than now. No council house building since the 1970s and the introduction of right to buyThe BTL model has worked well since the 1990’s.Properties were relatively cheapReturns were good, even with higher mortgage ratesWith higher interest rates so you could just about break-even, but enjoy fast capital growth Now the government thinks the pendulum swung too far in favour of landlords. Tenants are unhappy about high rents and insecurity. But is that the fault of landlords or a symptom of 50 years of short-term thinking government policy?The buy-to-let boom has led to a massive transfer of wealth into property, as well as the banks, and it seems the ‘powers that be’ want to apply the brakes with legislation and taxes, We are now living in a new socialist regime after 30 years of relatively business friendly government, which includes the Blair labour government. My personal experience30 years dealing with tenants - nothing against tenants, I just haven’t got the patience for it anymore!New threats from various BPU’s (business prevention units)Lack of social housing being built for 50 yearsMass immigration from all governments since the Blair years leading to an unprecedented population explosion Swinging from unrestrictive to tighter lendingPlanning hold-ups leading to housing shortageAnti-landlord policy starting with Conservative Chancellor George Osbourne and his Section 24 landlord taxRenters rights bill, which was born out of a conservative policyEnd of section 21 no fault of evictions and a ban on so-called “back door” evictionsOpen end of tenancies – how is that going to work in practice?New minimum housing standards and more red tape - many councils and large housing associations would fail these standards but only private landlords will be hitBan on Advanced rent payments, often used where tenants fail referencing or are from overseas. Even more rights for tenants Less security for property ownersBan “discrimination” Right to request adaptation of Properties in the case of disabilitiesRestrictions on rent increasesRent repayment ordersMore powers for local councils to sanction landlordsNew digital Landlord database, but no rouge tenant database County court backlogs, meaning that enforced evictions will take up to a year Renters rights was mentioned in parliament recently during PM’s questions after a labour MP raised the point that tenants were being priced out by landlords. Prime Minister Sir Keir Starmer said that his new renter’s rights bill will help 11 million tenants. He said they will end no fault of action something which the Conservatives had failed to do. . Landlords could be obliged to take pets and tenants on benefits Over the past year, only 6.6% of room-offered ads on SpareRoom explicitly welcomed pets, while a striking 93.4% did not. One third of people in the UK have pets and 29% own a cat. On a Spare room survey 93% of landlords display that they are unwilling to accept pets, this will be banned under the future law. If a tenant wants to keep a pet at home, landlords will not be able to unreasonably withhold their consent. If a tenant feels you’ve made an unfair decision they can challenge it by taking their complaint to the Private Rented Sector Ombudsman or even to court. Falling returns Soaring house prices means it’s difficult to get a positive yield on straightforward buy-to-let propertyLandlords have turned to HMO strategies, but local authorities are introducing more article 4 areas.The yields on properties in London and the Southeast have been driven down by high prices. Landlords are increasingly buying in the Midlands and the north of England, but who wants to drive 300 miles to find and manage property? Many have adapted and move into furnished Holiday lettings in order to avoid section 24 and the end of section 21 notices, but now the BPU are heading them off at the pass! Tax changes abolishing the advantages of furnished holiday Lettings , brought in by Jeremy “Hunt” the left leaning former Chancellor under the last ‘high tax’ conservative government. I know some landlord I’ve spoken to are happy to stay in the market and feel that they can adapt to the new laws. That’s fine there’s still a profit (sorry if that’s a dirty word, but without profit there is no service) to be made and in a long-term it’s still a good investment, but not for me and thousands of other landlords anymore. As the TV Dragons say, I’m out! Am I quitting property altogether? No! Property is still a good long-term investment and will survive the idiots that run the country downwards because the markets and demand will prevail. Despite warnings of our demise, the UK will also survive the fools in power. See other videos: Labour’s Renter’s Rights Bill and the end to Sec 21 ‘no fault evictions’ - https://www.youtube.com/watch?v=Wx1HXgVW1bM&t=400s&sttick=0 Nigel Farage SLAMS HMO BUY-to-Let Landlords In an astonishing attack on private enterprise, right wing Farage claimed that HMOs are not only damaging communities but are increasingly being used to house illegal migrants and asylum seekers, often at the taxpayer’s expense. Watch video - https://youtu.be/NKaPZj-APgw Better property strategies are needed. Learn property strategies from experts There are many more money making property strategies than buy-to-let. The important thing is to get the right property education from experts who have made millions in UK property. For more information on a free “NO MONEY DOWN PROPERTY” webinar, email charles@charleskelly.net #NigelFarage #HMOScandal #UKHousingCrisis #IllegalImmigrationUK #AsylumSeekersUK #HMOUK #PropertyInvesting #LandlordLife #UKPolitics #MoneyTips
In this episode, I'm delighted to welcome back our trusted specialist mortgage broker — Ellie Broadhurst.If you've been tuning in for a while, you'll already know that Ellie's insight into the lending market is second to none. She's right at the coalface, working with lenders and investors every day, and she has an incredible ability to cut through the noise and explain what's really going on.Since our last conversation, the base rate has been reduced — something we anticipated might be on the horizon. So in this episode, we unpack what that change actually means. We're talking mortgage products, swap rates, investor sentiment, market dynamics, and that all-important question: should you fix or track your mortgage?As always, Ellie brings practical advice, real-world context, and her signature no-nonsense style. Whether you're refinancing, planning your next purchase, or just trying to stay ahead in a shifting market, this episode is packed with value.Topics covered in this episode:02:54 Base Rate Reduction and Market Reactions06:02 Fixing vs. Tracking Mortgages08:52 Current Market Dynamics and Business Volumes12:02 Rental Market Trends and Tenant Behavior14:48 Future Predictions and Economic OutlookContact Ellie here, if you're interested in discussing your HMO mortgage and finance needs.-Did you find this episode useful? Please leave us a quick review on Apple Podcasts or Spotify!Got any questions? Join The HMO Community on Facebook!Connect with me on Instagram or Linkedin for daily HMO tips and advice! If you want to join my 1-2-1 mentoring program, you can enquire here. Feeling overwhelmed and don't know where to start? Join The HMO Roadmap on a Premium plan and get all-access to our award-winning library of 400+ resources to help you start, scale and systemise your HMO business. Get instant access here.
Welcome to another episode of The Blueprint Podcast. In this episode, we're welcoming Katie Harvey into the Property Entrepreneur Hall of Fame! From working 12-hour shifts as an electrician to becoming a successful Property Entrepreneur and co-director of Haines Homes, Katie's journey is one of transformation, resilience, and vision. Alongside her brother Josh and cousin Jacob, Katie started building a rent-to-rent HMO portfolio while still an apprentice—juggling long hours, low pay, and the constant grind of chasing invoices and managing projects. Like many entrepreneurs starting out, the business consumed their lives, leaving little time for family, hobbies, or rest. Everything changed when Katie joined the Property Entrepreneur Programme. With clear direction, expert mentorship, and the support of a like-minded community, she and her family were able to turn their business around. Katie got "off the tools", launched her passion project Breathe Blueprint, and began focusing on high-value work that delivered both profit and personal freedom. One of her most impressive achievements to date? Converting a 3-bed house into an 8-bed co-living space—projected to generate over £67,000 in profit. Through strategic planning, financial forecasting, and learning to treat family like business partners, Katie has not only built a thriving business, but reclaimed her time, her energy, and her life. Her story is a shining example of how building a Life by Design is not only possible—but powerful. Katie's top tips include: Create a clear plan—and review it regularly Surround yourself with the right people Celebrate the small wins And most importantly—enjoy the journey We hope you enjoy this episode and are inspired by Katie's journey of courage, clarity, and creating success on her own terms. Success and failure are both very predictable. Company Name: b.reathe / Haines Homes Company website: www.breatheblueprint.com / www.haineshomes.co.uk
#217Have you thought about flipping UK property to make some cash? Have you thought about buying a property to flip via the so-called modern method of auction using companies like I Am Sold? Have you wondered how to buy a property at discount without having to build relationships with lots and lots of estate agents in your chosen location? Well, if you thought about any of these three questions before then this episode is for you. And if you've thought about all three, then you're in for a treat!Simon Duckworth of Triangle Property Solutions actively sources and renovates properties for profit. With extensive experience in the auction space, Simon has developed a very strategic approach to property investment.We discuss:· Buy 3, sell 2, keep 1 strategy· Overview of traditional auctions· Overview of Modern Method· Tracking properties through multiple auction cycles / price reductions· Watching listings for signs of seller motivation· Step-by-Step Process of a flip listed on I am Sold· Probate properties / SDLT · The “no offer offer”· Importance of timing and repeated engagement through auction cycles· Refurb contingency· Conveyancing timelines · Selling strategy: price setting, agent selection, market testing· Differences in pricing strategy between corporate and family-run agents· Holding / selling costs· Risks / challenges in Flips· Risks: time overruns, market sentiment, refurb estimates· Tips for Successful Flipping· Need for organization / tracking· Testing market prices / negotiation: “Say No Twice” strategy· Buffers (refurb AND time)· Maximizing Profit and Market Adaptation· Expectations (profit / timelines)· Adapting to slower / fluctuating markets.· Lessons from HMO Challenges: Regulatory Headaches· Simon's near disaster with a large HMO project due to neighbor complaints.Free Deal ClinicI'd Like Help With Setting My GoalsLeave a reviewJoin our WhatsApp group / access 37 Question Due Diligence Checklist / 23 Step Guide to Buying Property at AuctionInstagramKeywordsUK property flipping, modern method of auction, I am sold, property discounts, estate agents, investing capital, buy to flip, auction property sourcing, flipping strategies, property renovation, HMO investment, property refurb costs, auction cycle tracking, probate property, stamp duty savings, reservation fee, online property auctions, property market sentiment, conveyancing delays, property holding costs, selling strategies, estate agent negotiation, real estate CRM, flips vs
I'm sharing a recent conversation I had as a guest on The BEESPACE Podcast, hosted by my good friend Jade McNeil.Jade and I covered a wide range of topics—not just HMOs and property—but also the bigger-picture stuff: balancing life and business, navigating challenges, and the personal shifts that come with experiences like becoming a parent or facing health scares.It's a really open and honest chat. If you're running a business, managing a property portfolio, or simply trying to keep up with everything life throws at you, I think you'll find this episode both relatable and insightful.Topics covered in this episode:09:02 - Career Transition From Physiotherapy to Property21:05 - Building Arcvelop Investor Group27:57 - Navigating the Challenges of Property Development31:09 - Building Credibility Through Consistency33:45 - Creating The HMO Community and The HMO Roadmap39:17 - Navigating Social Media Challenges47:09 - The Impact of Fatherhood on Business-Did you find this episode useful? Please leave us a quick review on Apple Podcasts or Spotify!Got any questions? Join The HMO Community on Facebook!Connect with me on Instagram or Linkedin for daily HMO tips and advice! If you want to join my 1-2-1 mentoring program, you can enquire here. Feeling overwhelmed and don't know where to start? Join The HMO Roadmap on a Premium plan and get all-access to our award-winning library of 400+ resources to help you start, scale and systemise your HMO business. Get instant access here.
I detta avsnittet pratar vi om olika sätt att öka värdet och maximera utnyttjandet av en fastighet.Vi går även in lite på skillnader mellan små och större projekt.Nätverksträff 15 maj i Stockholm - Anmäl dig här!Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-april-2025Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
Nigel Farage has once again ignited controversy, this time turning his sights on the UK’s House in Multiple Occupation (HMO) sector. Speaking out this week at a Reform press conference in Dover, Farage claimed that HMOs are not only damaging communities but are increasingly being used to house illegal migrants and asylum seekers, often at the taxpayer’s expense. Watch video - https://youtu.be/NKaPZj-APgw Farage, who could become the next UK Prime Minister according to the polls and recent local election results, argued that the rapid growth of HMOs—particularly in urban areas—is "a symptom of a failed immigration and housing policy." He criticised how private landlords and government contracts are turning residential streets into overcrowded multi-let properties, undermining local cohesion and public services. While HMOs can be a profitable property strategy, especially for landlords seeking higher yields, they’ve become controversial. Local residents often complain about noise, rubbish, overcrowding, parking and falling property values. Councils have responded with Article 4 directions and tougher licensing schemes. Is this another nail in the coffin for buy-to-let property investment, and further reasons for landlords to get out of the UK property market? In recent years, landlords have had to contend with: Section 24 landlord tax – watch accountant explain tax and solutions - https://youtu.be/aMuGs_ek17s Increased tax and Increased red tape and regulation. Now, landlords are facing Labour’s Renter’s Rights Bill and the end to Sec 21 ‘no fault evictions’. See full episode - https://www.youtube.com/watch?v=Wx1HXgVW1bM&t=400s The latest episode of the Charles Kelly Money Tips Podcast explores the truth behind these claims, what it means for property investors, and the future of HMO investments in the UK. Please like and subscribe - https://www.youtube.com/@charleskellymoneytipspodca9121 In the next Charles Kelly Money Tips Podcast episode, I will tell you why I’m getting out of buy-to-let property after 30 years! There are many more money making property strategies than buy-to-let. The important thing is to get the right property education from experts who have made millions in UK property. For more information on a free “NO MONEY DOWN PROPERTY” webinar, email charles@charleskelly.net #NigelFarage #HMOScandal #UKHousingCrisis #IllegalImmigrationUK #AsylumSeekersUK #HMOUK #PropertyInvesting #LandlordLife #UKPolitics #MoneyTips This Podcast has been brought to you by Disruptive Media. https://disruptivemedia.co.uk/
Welcome to HALO Talks! In this episode, host Pete Moore sits down with Tom Morrissey, founder of Solo Health Collective and a seasoned veteran in the health insurance world, to unpack the complex—and often misunderstood—landscape of healthcare for self-employed professionals. With a career spanning decades at Cigna and deep experience serving everyone from major corporations to solo entrepreneurs, Tom shares how he's dedicated his life to helping small business owners and solopreneurs access quality, affordable health coverage. Despite his success in the large-account space, Tom noticed an unmet need: Small and mid-sized businesses were often overlooked by health insurers and weren't given access to innovative cost-saving or health improvement solutions that benefited the bigger corporations. If you're a personal trainer, group ex instructor, wellness coach, massage therapist, or any professional running your own business, this conversation is a game changer. Tom explains the differences between HMO and PPO plans, why traditional ACA ("Affordable Care Act") options can fall short for the self-employed, and how his company's unique group plan model is designed to deliver robust coverage (including preventive care and nationwide access) with transparent pricing and minimal out-of-pocket surprises. Plus, hear about partnerships with organizations like the Freelancers Union, and learn how innovative features like HSAs can work for you—even covering perks like fitness classes. On the healthcare issues facing entrepreneurs, Morrissey states, "We saw the growth. It depends on who you listen to, but estimates are that there'll be 90M solo business, owners by 2028. I want to say there's about 60M now. The guys and gals that own these businesses . . . I think, especially when they're young and healthy, are the ones that get screwed the most in healthcare. You know? All they really have access to is ACA plans." Key themes discussed Challenges of health insurance for solopreneurs and self-employed. Differences between PPO and HMO health plans. Underwriting and rate-setting for solo business owners. Preventive care coverage and HSA/HSA usage changes. Brand trust versus new insurance providers like Solo Health Collective. Partnerships with organizations such as Freelancers Union. Long-term cost sustainability for healthier insurance collectives. A few key takeaways: 1. Solo Health Plans Are Filling a Major Gap: Morrissey explains how traditional health insurance often overlooks solopreneurs and small business owners, especially in the HALO space. His company, Healthy Business Group via Solo Health Collective, is designed specifically to provide comprehensive PPO health plans to solo business owners—offering an alternative with more flexibility and better coverage than typical limited-network ACA and HMO options. 2. Key Plan Advantages-PPO Access and Maximum Out-of-Pocket Clarity: Unlike many ACA or HMO plans that limit provider networks and access, Solo Health Collective offers nationwide PPO plans, granting members broader access to healthcare providers. They also have a straightforward approach: After the deductible is met, there's no coinsurance—meaning your deductible is the absolute maximum you'll pay out-of-pocket for covered expenses (with all preventative care covered in full and not applied to the deductible). 3. Plans Are Designed for Solo Business Owners With Medical Underwriting: To qualify, you must have an EIN (Employer Identification Number) and be a business owner without employees. Members go through a quick, five-question medical underwriting process, which allows the plan to provide tailored age, and location-based rates—often significantly less expensive than standard individual policies, especially for young, healthy professionals. 4. HSAs and Innovative Usage for Wellness Are Embraced: The plan supports health savings accounts (HSAs), and Tom shared how, thanks to evolving IRS guidelines and technology, people can now use HSA funds for things like fitness classes and certain wellness purchases, expanding the value of pre-tax health dollars and encouraging preventive care and healthy lifestyles. 5. Long-Term Value and Stability Solo Health Collective is built on a self-insured, level-funded model supported by robust reinsurance (Odyssey A+ rated.) This allows the collective to stabilize costs and potentially keep renewal increases lower than the industry average—especially as it pools healthier, proactive members like those in the wellness and fitness industries. The long-term goal is to create a sustainable, affordable health insurance solution specifically for entrepreneurs who have historically been underserved. Resources: Thomas Morrissey: https://www.linkedin.com/in/tommorrisseyhbg Solo Health Collective: https://hbgsolo.com How It Works: https://hbgsolo.com/how-it-works Freelancers Union: https://freelancersunion.org/insurance/health Promotion Vault: http://www.promotionvault.com HigherDose: http://www.higherdose.com
A homeowner has issued a stark warning after he says his life was “destroyed completely” by having an HMO next door.The resident in Sittingbourne was stunned to wake up and find scaffolding and the roof missing on the adjoining property in the terraced street.Also in today's podcast, a mum has branded Medway council “clueless” after it wrongly refused her 17-year-old daughter a parking permit — and then asked for hers back as well.She'd applied on behalf of the learner driver for an additional pass to park outside the family's terraced home in Gillingham but the authority insisted they aren't living within a controlled parking zone. People living at an retirement complex fear “every day will become a nightmare” if a live music venue opens directly opposite.Those living in Folkestone town centre say the prospect of late-night music and “people drinking on the street” is making them “incredibly anxious”.Plans have resurfaced to convert a pub into a place of worship - just six months after they were refused.Charity Al-Haqq Academy initially wanted to transform the ground floor of the now-closed public house into an academy with community and religious services, including a prayer hall, a food bank, a youth club, and a mosque.And there's been plenty of football action across the long weekend – with Gillingham FC, Maidstone United and Dover Athletic all having reason to celebrate. We've spoken to their managers about unbeaten streaks, league finals and promotion.
We welcome back Tom Appleton, Property Entrepreneur Board Member who featured on TBP Episode 188 on 1st December 2023. Tom is based in Leeds and he shares his background of moving to L.A. to play football, why he moved into coaching and how he first got interested in property investing. Tom joined Property Entrepreneur in 2019 and met one of his business partners that year, Garrett Peers, who is now also a Board Member. Tom focuses on good quality HMOs and apartment blocks in the Leeds and Wakefield area. On Property Entrepreneur, we cover the 3 levels of Wealth Creation and these 3 deals are all great assets for The Financial Fortress. Here are the numbers for these 3 deals: 2 high end apartments and ground floor commercial Purchase price: £360,000 Refurb and costs £250,000 End valuation £1,000,000 Equity: £350,000 Lease rents: £6900 pm Cashflow: £3500 pm / £42,000 pa 7 to 8 bed HMO conversion Purchase Price £405,000 Refurb £60,000 End value: £600,000 Equity: £120,000 Rents: £5250 pm Cashflow: £3000 pm / £36,000 pa 4 to 6 bed HMO conversion Purchase price £270,000 Refurb £90,000 End value: £500,000 Equity: £120,000 Rents: £4500 pm / £54,000 pa Cashflow: £2500 pm / £30,000 pa Want to contact Mark or his guests? www.thepropertybrokerage.co.uk mark@thepropertybrokerage.co.uk Tom Appleton info@tenequity.com Instagram- @tomappleton10 Facebook- Tom Appleton LinkedIn- Tom Appleton
I det här avsnittet delar vi med oss av våra bästa tips kring inredning av HMO – från hur du bör tänka vid finansiering till praktiska råd kring möblering och design. Ett avsnitt fullt av värdefulla insikter!Nätverksträff 15 maj i Stockholm - Anmäl dig här!Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-mars-2025Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
In this episode of WealthTalk, we're joined by Raj Beri, a former scientist turned full-time property investor, who reveals how he built a successful portfolio using innovative strategies—including the Local Housing Allowance (LHA) model) to maximise rental income. With hosts Christian Rodwell and Kevin Whelan, Raj unpacks the complexities of navigating housing benefit tenants, government regulations, and tenant relationships, while debunking common myths that deter many investors from exploring this path.Raj shares the ups and downs of leaving behind a stable career, the importance of having a financial safety net, and how mentorship and community support have been key pillars in his property journey. He speaks candidly about the challenges of tenant management, the need for adaptability in an ever-changing market, and how leveraging his corporate skills helped him become a more effective landlord and investor.The episode also highlights Raj's belief that anyone can succeed in property with the right mindset, education, and support. Whether you're just getting started or looking to expand your strategy, this conversation offers practical insights into achieving long-term wealth through property.This episode is essential listening for aspiring and experienced property investors alike—especially those curious about high-cashflow models, buy-to-let, HMOs, and building resilience in the face of regulatory change.Tune in now to learn how Raj Beri transformed his life through property investment—and how you can too.Resources Mentioned In This Episode: >> Raj Beri [LinkedIn]>> Raj Beri [Website]>> Brand New! Wheel of WealthNext Steps On Your Wealth Building Journey: >> Join the WealthBuilders Facebook Community >> Schedule a 1:1 call with one of our team >> Become a member of WealthBuilders If you have been enjoying listening to WealthTalk - Please Leave Us A Review!
I det här avsnittet summerar vi vad som hänt under Q1 både privat och i företaget. Vi delar också med oss av vår senaste resa till Storbritannien för två veckor sedan, med insikter, reflektioner och uppdateringar från marken. Häng med!Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-mars-2025Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
The Medicare Advantage Minute points out more trouble for Medicare Advantage plans. Hospitals have seen increasingly aggressive denials of payments with every expectation of more denial pressure to come! In Your Medicare Benefits 2024 we learn how Medicare covers doctor services. No secret, their fees are Part B expenses. Finally, we hear from Linda, wife of a happy MLM Medicare supplement client. Two years away from Medicare age herself, she is concerned because her favorite hospital and long-time doctor have been deemed "out of network" due to a merger or an acquisition. Turns out she has a PPO plan, not an HMO. Even though these providers are "out-of-network" they are not out-of-bounds to Linda. For a somewhat less robust insurance coverage she will still be able to use them at will. Two years from now, with original Medicare plus a supplement, her network concerns should be a thing of the past. I am looking forward to helping Linda join her husband as another happy client! Contact me at: DBJ@MLMMailbag.com (Most severe critic: A++) Visit us on: BabyBoomer.ORG Inspired by: "MEDICARE FOR THE LAZY MAN 2025; Simplest & Easiest Guide Ever!" on Amazon.com. Return to leave a short customer review & help future readers. Official website: https://www.MedicareForTheLazyMan.com.
There are fears horror stories from the county's A&E departments have left many patients afraid to seek urgent hospital treatment.Reports of sick people stranded for hours on trolleys in crowded corridors are having a knock-on effect on local surgeries.Also in today podcast, a drink driver was warned she could be facing jail after admitting to getting behind the wheel while over the legal limit for at least the third time.She was spotted by police at the wheel of her car in Maidstone in February “driving at excess speed” and going in a bus lane.Dozens of Evri couriers are being chased by debt collectors after their depot decided to install private parking cameras.Early time slot drivers at the depot in Strood were told ANPR cameras were going live in November to stop unauthorised parking – but more than 20 have received penalty notices. Ambitious plans for a new four-storey HMO building in the rear yard of an existing property in Maidstone town centre have been submitted.Housing bosses want to build a 10-bed house of multiple occupation in Week Street despite concerns over a lack of vehicle access. And in football, it was a big weekend for the Gillingham boss after he notched up his first win since joining the club. You can hear from Gareth Ainsworth and goal scorer Bradley Dack following their 1 – nil win over MK Dons at the weekend.
Two men have gone on trial accused of murder after another man was stabbed through the heart during an attack in Canterbury.23 year-old Samare Gerezgihir - who was also known as Sammy or Jamyl - died at the scene in a courtyard near the former Nasons department store in the city centre in October last year.People living in two Kent villages fear they could be left without high-speed wifi after a provider announced plans to pull out of the area.Trooli's confirmed a small number of customers on a copper network in Stansted and part of Fairseat will be affected.A Kent dad who's raised tens of thousands of pounds for charity after being diagnosed with terminal prostate cancer has won a top award.Paul Dennington has taken part in various challenges, and was recognised at the Pride in Medway event.His latest campaign will see him walk 25 million steps on a month-long journey from Newcastle to Medway.Kent property developers have been talking to the Podcast about how they're setting out to "level up" the shared accommodation game.Aaron Prowse and Ellis O'Sullivan currently have nine HMOs in Medway and Gravesend - and are in the process of buying another four, with two more in construction.A Kent chocolate company has created the UK's biggest and heaviest Easter Egg.It's seven feet tall and weighs 300 kilograms - which is the same as a polar bear.And in sport, Gillingham are on the road again as they take on Chesterfield tonight.It's a quick turnaround for the Gills who secured a point at Salford City on Saturday with a 2-2 draw.
Rob Main helps people of all ages at Rob Main Health and Wellness. That puts him deep into the world of Health coverage and Medicare. Learn what you need to know about the ups and downs of Medicare. Like this episode? Hit that Follow button and never miss an episode!
SOUNDBROKER PRESENTS: Thinking Out Loud w/Friends ZoomCastAN OPEN CONVERSATION WITH FRIENDS THAT LOVE THE WORLD OF CONCERT AND SPECIAL EVENT PRODUCTIONSJoin our current events support zoomcast show hosted by Jan Landy and his knowledgeable affable panel of friends and colleagues for an entertaining robust discussion offering opinions on anything related to a working professional life in general.Our ZoomCast isn't just a fountain of knowledge; it's also a opportunity to laugh. Think of it as therapy, but with more jokes and fewer couches. Join us and share your thoughts. Stay updated on life and world events, and enjoy multiple good chuckles along the way.
Ready to unlock your Property Investment game in 2025? Grab your FREE copy of the guide today and master the Buy-to-Let market https://bit.ly/buy-to-let-hotspots-guide2025——————————————————In this episode of This Property Life Podcast, host Sarah Blaney is joined by property expert Elaine Bailey to discuss the property market in the Wirral, a thriving region in the Northwest of England. Elaine, a seasoned letting and estate agent, shares her insights into the demand for different types of rentals, investment potential, and what makes the Wirral an attractive location for buy-to-let and HMO investors.What You'll Learn:Why the Wirral is a growing hotspot for property investmentThe demand for different types of rental properties in the regionKey factors to consider before investing in the WirralHow local estate and letting agents assess market trendsTips for property investors looking to expand their portfolioTimestamps:[01:51] – Meet Elaine Bailey: Lettings and estate agent in the Wirral [08:31] – Current room rental rates in the Wirral [18:51] – Is there still demand for HMOs in the Wirral? [19:49] – Expected yields for HMOs in the current market [33:55] – How to connect with Elaine Bailey for property advice This Episode is Kindly Sponsored by: Visit thispropertylife.co.uk for more resources, networking events, and industry insights.Follow Elaine Bailey Socials:LinkedIn: https://www.linkedin.com/in/elaine-bailey-85bb8213a Company(Linkedin): https://www.linkedin.com/company/bailey-and-staples-property-specialists/about/ Company(Website): https://baileyandstaples.co.uk/ Email: info@baileyandstaples.co.ukFollow This Property Life Podcast on Socials:Instagram: https://www.instagram.com/thispropertylife/# Facebook: https://www.facebook.com/profile.php?id=61564457166712&locale=en_GB LinkedIn: https://www.linkedin.com/company/this-property-life-podcast/about/ Tiktok: https://www.tiktok.com/@thispropertylife?lang=en Twitter: https://x.com/propertylifepod Hosted on Acast. See acast.com/privacy for more information.
Venture capital in healthcare has evolved from "the trailer park of venture investing" to a fundamental core tenant of the ecosystem, reflecting a quarter-century transformation of the entire industry.In this episode, we sit down with Mohamad Makhzoumi, co-CEO of NEA, who shares his 25-year journey from unpaid intern to leader of one of the largest healthcare investment funds, offering his insights into the evolution of healthcare startups and VC.We cover:
I det här avsnittet intervjuar Nana sin vän Kenneth, som har erfarenhet av den spanska bostadsmarknaden. Vi dyker ner i vad som skiljer den spanska fastighetsmarknaden från den brittiska från köpprocess och finansiering till investeringsstrategier och utmaningar. Kenneth delar med sig av värdefulla insikter och ger sina bästa tips för den som funderar på att investera i Spanien.Kontakt uppgifterKennethason@hotmail.com0733-580561Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-mars-2025Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
Simon delves into two lucrative property investment strategies: Houses of Multiple Occupation (HMOs) and serviced accommodation, comparing the benefits and challenges of each approach, highlighting the importance of quality in HMOs to attract better tenants and ensure consistent income. He discusses the need for effective management and the potential for repeat customers in the Airbnb market, while also discussing the impact of upcoming regulations on short-term rentals. KEY TAKEAWAYS HMOs provide consistent income through long-term contracts (typically 6-12 months) and can yield a profit of at least £1,000 per property when managed correctly. High-end co-living HMOs are recommended to attract better tenants and avoid competing solely on price. Airbnb properties can generate significant income, but the occupancy rates can fluctuate, averaging around 70%. Dynamic pricing is essential to maximise profits based on demand, and maintaining good reviews is crucial for attracting repeat customers. Recent regulations in Scotland and Wales, with potential upcoming regulations in England, may impact the Airbnb market by requiring safety standards and registration. This could reduce supply and benefit those who remain in the market. Successful property investing involves not doing all the work personally. Utilising managing agents for HMOs and virtual assistants for Airbnb can help streamline operations, allowing investors to focus on growing their portfolio while maintaining a work-life balance. BEST MOMENTS "If you have a vanilla boring HMO, you're going to compete on price, which is not a good thing." "The key to making lots of money in SA, Airbnb, is to get repeat customers. It's very important to get really good reviews." "When regulation comes in, there'll be a fall in supply of Airbnb and service accommodation units available to rent." "If you look after your tenants in an HMO, I've got tenants who've stayed for years and years and years." "Please treat your property investing like a business, systemise it and get great people in to help you run that business." VALUABLE RESOURCES To learn more about how you can add profitable HMOs to your portfolio, register here to join online training with Simonhttps://property.isrefer.com/go/3-5PF/Podcast/ To find your local pin meeting visit: www.PinMeeting.co.uk and use voucher code PODCAST to attend you first meeting as Simon's guest (instead of paying the normal £20). Contact and follow Simon here: Facebook: http://www.facebook.com/OfficialSimonZutshi LinkedIn: https://www.linkedin.com/in/simonzutshi/ YouTube: https://www.youtube.com/SimonZutshiOfficial Twitter: https://twitter.com/simonzutshi Instagram: https://www.instagram.com/simonzutshi/ Simon Zutshi, experienced investor, successful entrepreneur and best-selling author, is widely recognised as one of the top wealth creation strategists in the UK. Having started to invest in property in 1995 and went on to become financially independent by the age of 32. Passionate about sharing his experience, Simon founded the property investor’s network (pin) in 2003 www.pinmeeting.co.uk pin has since grown to become the largest property networking organisation in the UK, with monthly meetings in 50 cities, designed specifically to provide a supportive, educational and inspirational environment for people like you to network with and learn from other successful investors. Since 2003, Simon has taught thousands of entrepreneurs and business owners how to successfully invest in a tax-efficient way. How to create additional streams of income, give them more time to do the things they want to do and build their long-term wealth. Simon’s book “Property Magic” which is now in its sixth edition, became an instant hit when first released in 2008 and remains an Amazon No 1 best-selling property book. Simon launched his latest business, www.CrowdProperty.com, in 2014, which is an FCA Regulated peer to peer lending platform to facilitate loans between private individuals and property professionals.
We are excited to bring our listeners another Practice Growth Deep Dive Episode of the Growth in Dentistry Podcast. This episode takes you along with Steve and Adam into Dr. Maggie Augustyn's dental journey and the changes she made to have a growing and healthy practice. Listen along to hear:Her practice's transformation from a high-volume HMO/public aid practice to a quality-focused practice during COVID-19What changes she and her team made to the type of procedures they were accepting and renegotiating insurance feesHer patient care evolution - enabling more comprehensive care and better relationshipsThe quality of life impact for Dr. Maggie and how she sees dentistry nowAbout the technology she and her team have invested inDr. Maggie's advice for dentists…and so much more!We packed a lot into these 45 minutes, so buckle up and enjoy learning from Dr. Maggie Augustyn!See a demo of DI and get a $50 gift card: https://get.dentalintel.net/podcast.
I detta avsnitt går vi igenom alla utmaningar vi stött på i våra projekt. Vill du se videon istället för att lyssna? Klicka på YouTube-länken eller kolla in avsnittet på Spotify!Vill du följa våra renoveringar ?https://chat.whatsapp.com/LJXM6Fx3qC67WeN2zqr63hVill du avgöra om fastighetsinvesteringar i Storbritannien är rätt för dig? www.miracle-academy.se/courses/grundkursVill ni gå med i vår mastermind (masterminden kräver tidigare utbildning eller erfarenhet) mm@miraclepropertiesltd.comVill du ta lära dig om HMO? Kolla in vår kurs inom det!https://www.miracle-academy.se/courses/hmoOm ni vill boka upp ett samtal med oss tryck på Calendly länken https://calendly.com/miraclepropertiesltd/15minMissade du vårt senaste nyhetsbrev? Se till att kolla in det för att hålla dig uppdaterad med de senaste nyheterna och händelserna inom fastighetsinvesteringar i UK.https://mailchi.mp/miraclepropertiesltd/senaste-nyheterna-december-10939404Tack till alla som lyssnar, betygsätter och ställer frågor. Vi uppskattar er alla!Följ oss gärna
Simon welcomes Richard Miller, a former army officer turned successful property investor, who shares his incredible journey into the world of real estate. Richard discusses a life-changing mega deal that generated over £100,000 in profit from a single investment, highlighting the importance of education and networking in property investing. He also recounts his initial foray into property after being inspired by his father's advice, leading to a series of successful investments, including a remarkable 48-bed HMO in Sheffield. KEY TAKEAWAYS Gaining knowledge about property investment is crucial. Understanding the risks and having a solid support network transforms a gamble into a calculated risk. Simply acquiring knowledge is not enough; taking decisive action is essential for changing one's life and achieving financial goals. Focusing on larger property deals can lead to greater profits with less competition. By moving away from smaller, saturated markets, investors can find more lucrative opportunities. Building a strong network of investors and partners can provide the necessary funding and experience to tackle larger projects that may initially seem out of reach. BEST MOMENTS "I thought I could earn more than that, hopefully with less work and be my own boss through property investing." "I found a six bed student HMO in Sheffield, off market, bricks and mortar value 345, agreed to buy it for 325." "I had no money again and had to, right, do I phone up John... or do I try and do this and try and make it work?" "If you want something different for your life, you've got to do something different." VALUABLE RESOURCES To learn more about how you can add profitable HMOs to your portfolio, register here to join online training with Simon https://property.isrefer.com/go/3-5PF/Podcast/ To find your local pin meeting visit: www.PinMeeting.co.uk and use voucher code PODCAST to attend you first meeting as Simon's guest (instead of paying the normal £20). Contact and follow Simon here: Facebook: http://www.facebook.com/OfficialSimonZutshi LinkedIn: https://www.linkedin.com/in/simonzutshi/ YouTube: https://www.youtube.com/SimonZutshiOfficial Twitter: https://twitter.com/simonzutshi Instagram: https://www.instagram.com/simonzutshi/ Simon Zutshi, experienced investor, successful entrepreneur and best-selling author, is widely recognised as one of the top wealth creation strategists in the UK. Having started to invest in property in 1995 and went on to become financially independent by the age of 32. Passionate about sharing his experience, Simon founded the property investor’s network (pin) in 2003 www.pinmeeting.co.uk pin has since grown to become the largest property networking organisation in the UK, with monthly meetings in 50 cities, designed specifically to provide a supportive, educational and inspirational environment for people like you to network with and learn from other successful investors. Since 2003, Simon has taught thousands of entrepreneurs and business owners how to successfully invest in a tax-efficient way. How to create additional streams of income, give them more time to do the things they want to do and build their long-term wealth. Simon’s book “Property Magic” which is now in its sixth edition, became an instant hit when first released in 2008 and remains an Amazon No 1 best-selling property book. Simon launched his latest business, www.CrowdProperty.com, in 2014, which is an FCA Regulated peer to peer lending platform to facilitate loans between private individuals and property professionals.
Dr. Gary Null provides a commentary on "Universal Healthcare" Universal Healthcare is the Solution to a Broken Medical System Gary Null, PhD Progressive Radio Network, March 3, 2025 For over 50 years, there has been no concerted or successful effort to bring down medical costs in the American healthcare system. Nor are the federal health agencies making disease prevention a priority. Regardless whether the political left or right sponsors proposals for reform, such measures are repeatedly defeated by both parties in Congress. As a result, the nation's healthcare system remains one of the most expensive and least efficient in the developed world. For the past 30 years, medical bills contributing to personal debt regularly rank among the top three causes of personal bankruptcy. This is a reality that reflects not only the financial strain on ordinary Americans but the systemic failure of the healthcare system itself. The urgent question is: If President Trump and his administration are truly seeking to reduce the nation's $36 trillion deficit, why is there no serious effort to reform the most bloated and corrupt sector of the economy? A key obstacle is the widespread misinformation campaign that falsely claims universal health care would cost an additional $2 trillion annually and further balloon the national debt. However, a more honest assessment reveals the opposite. If the US adopted a universal single-payer system, the nation could actually save up to $20 trillion over the next 10 years rather than add to the deficit. Even with the most ambitious efforts by people like Elon Musk to rein in federal spending or optimize government efficiency, the estimated savings would only amount to $500 billion. This is only a fraction of what could be achieved through comprehensive healthcare reform alone. Healthcare is the largest single expenditure of the federal budget. A careful examination of where the $5 trillion spent annually on healthcare actually goes reveals massive systemic fraud and inefficiency. Aside from emergency medicine, which accounts for only 10-12 percent of total healthcare expenditures, the bulk of this spending does not deliver better health outcomes nor reduce trends in physical and mental illness. Applying Ockham's Razor, the principle that the simplest solution is often the best, the obvious conclusion is that America's astronomical healthcare costs are the direct result of price gouging on an unimaginable scale. For example, in most small businesses, profit margins range between 1.6 and 2.5 percent, such as in grocery retail. Yet the pharmaceutical industrial complex routinely operates on markup rates as high as 150,000 percent for many prescription drugs. The chart below highlights the astronomical gap between the retail price of some top-selling patented pharmaceutical medications and their generic equivalents. Drug Condition Patent Price (per unit) Generic Price Estimated Manufacture Cost Markup Source Insulin (Humalog) Diabetes $300 $30 $3 10,000% Rand (2021) EpiPen Allergic reactions $600 $30 $10 6,000% BMJ (2022) Daraprim Toxoplasmosis $750/pill $2 $0.50 150,000% JAMA (2019) Harvoni Hepatitis C $94,500 (12 weeks) $30,000 $200 47,000% WHO Report (2018) Lipitor Cholesterol $150 $10 $0.50 29,900% Health Affairs (2020) Xarelto Blood Thinner $450 $25 $1.50 30,000% NEJM (2020) Abilify Schizophrenia $800 (30 tablets) $15 $2 39,900% AJMC (2019) Revlimid Cancer $16,000/mo $450 $150 10,500% Kaiser Health News (2021) Humira Arthritis $2,984/dose $400 $50 5,868% Rand (2021) Sovaldi Hepatitis C $1,000/pill $10 $2 49,900% JAMA (2021) Xolair Asthma $2,400/dose $300 $50 4,800% NEJM (2020) Gleevec Leukemia $10,000/mo $350 $200 4,900% Harvard Public Health Review (2020) OxyContin Pain Relief $600 (30 tablets) $15 $0.50 119,900% BMJ (2022) Remdesivir Covid-19 $3,120 (5 doses) N/A $10 31,100% The Lancet (2020) The corruption extends far beyond price gouging. Many pharmaceutical companies convince federal health agencies to fund their basic research and drug development with taxpayer dollars. Yet when these companies bring successful products to market, the profits are kept entirely by the corporations or shared with the agencies or groups of government scientists. On the other hand, the public, who funded the research, receives no financial return. This amounts to a systemic betrayal of the public trust on a scale of hundreds of billions of dollars annually. Another significant contributor to rising healthcare costs is the widespread practice of defensive medicine that is driven by the constant threat of litigation. Over the past 40 years, defensive medicine has become a cottage industry. Physicians order excessive diagnostic tests and unnecessary treatments simply to protect themselves from lawsuits. Study after study has shown that these over-performed procedures not only inflate costs but lead to iatrogenesis or medical injury and death caused by the medical system and practices itself. The solution is simple: adopting no-fault healthcare coverage for everyone where patients receive care without needing to sue and thereby freeing doctors from the burden of excessive malpractice insurance. A single-payer universal healthcare system could fundamentally transform the entire industry by capping profits at every level — from drug manufacturers to hospitals to medical equipment suppliers. The Department of Health and Human Services would have the authority to set profit margins for medical procedures. This would ensure that healthcare is determined by outcomes, not profits. Additionally, the growing influence of private equity firms and vulture capitalists buying up hospitals and medical clinics across America must be reined in. These equity firms prioritize profit extraction over improving the quality of care. They often slash staff, raise prices, and dictate medical procedures based on what will yield the highest returns. Another vital reform would be to provide free medical education for doctors and nurses in exchange for five years of service under the universal system. Medical professionals would earn a realistic salary cap to prevent them from being lured into equity partnerships or charging exorbitant rates. The biggest single expense in the current system, however, is the private health insurance industry, which consumes 33 percent of the $5 trillion healthcare budget. Health insurance CEOs consistently rank among the highest-paid executives in the country. Their companies, who are nothing more than bean counters, decide what procedures and drugs will be covered, partially covered, or denied altogether. This entire industry is designed to place profits above patients' lives. If the US dismantled its existing insurance-based system and replaced it with a fully reformed national healthcare model, the country could save $2.7 trillion annually while simultaneously improving health outcomes. Over the course of 10 years, those savings would amount to $27 trillion. This could wipe out nearly the entire national debt in a short time. This solution has been available for decades but has been systematically blocked by corporate lobbying and bipartisan corruption in Washington. The path forward is clear but only if American citizens demand a system where healthcare is valued as a public service and not a commodity. The national healthcare crisis is not just a fiscal issue. It is a crucial moral failure of the highest order. With the right reforms, the nation could simultaneously restore its financial health and deliver the kind of healthcare system its citizens have long deserved. American Healthcare: Corrupt, Broken and Lethal Richard Gale and Gary Null Progressive Radio Network, March 3, 2025 For a nation that prides itself on being the world's wealthiest, most innovative and technologically advanced, the US' healthcare system is nothing less than a disaster and disgrace. Not only are Americans the least healthy among the most developed nations, but the US' health system ranks dead last among high-income countries. Despite rising costs and our unshakeable faith in American medical exceptionalism, average life expectancy in the US has remained lower than other OECD nations for many years and continues to decline. The United Nations recognizes healthcare as a human right. In 2018, former UN Secretary General Ban Ki-moon denounced the American healthcare system as "politically and morally wrong." During the pandemic it is estimated that two to three years was lost on average life expectancy. On the other hand, before the Covid-19 pandemic, countries with universal healthcare coverage found their average life expectancy stable or slowly increasing. The fundamental problem in the U.S. is that politics have been far too beholden to the pharmaceutical, HMO and private insurance industries. Neither party has made any concerted effort to reign in the corruption of corporate campaign funding and do what is sensible, financially feasible and morally correct to improve Americans' quality of health and well-being. The fact that our healthcare system is horribly broken is proof that moneyed interests have become so powerful to keep single-payer debate out of the media spotlight and censored. Poll after poll shows that the American public favors the expansion of public health coverage. Other incremental proposals, including Medicare and Medicaid buy-in plans, are also widely preferred to the Affordable Care Act or Obamacare mess we are currently stuck with. It is not difficult to understand how the dismal state of American medicine is the result of a system that has been sold out to the free-market and the bottom line interests of drug makers and an inflated private insurance industry. How advanced and ethically sound can a healthcare system be if tens of millions of people have no access to medical care because it is financially out of their reach? The figures speak for themselves. The U.S. is burdened with a $41 trillion Medicare liability. The number of uninsured has declined during the past several years but still lingers around 25 million. An additional 30-35 million are underinsured. There are currently 65 million Medicare enrollees and 89 million Medicaid recipients. This is an extremely unhealthy snapshot of the country's ability to provide affordable healthcare and it is certainly unsustainable. The system is a public economic failure, benefiting no one except the large and increasingly consolidated insurance and pharmaceutical firms at the top that supervise the racket. Our political parties have wrestled with single-payer or universal healthcare for decades. Obama ran his first 2008 presidential campaign on a single-payer platform. Since 1985, his campaign health adviser, the late Dr. Quentin Young from the University of Illinois Medical School, was one of the nation's leading voices calling for universal health coverage. During a private conversation with Dr. Young shortly before his passing in 2016, he conveyed his sense of betrayal at the hands of the Obama administration. Dr. Young was in his 80s when he joined the Obama campaign team to help lead the young Senator to victory on a promise that America would finally catch up with other nations. The doctor sounded defeated. He shared how he was manipulated, and that Obama held no sincere intention to make universal healthcare a part of his administration's agenda. During the closed-door negotiations, which spawned the weak and compromised Affordable Care Act, Dr. Young was neither consulted nor invited to participate. In fact, he told us that he never heard from Obama again after his White House victory. Past efforts to even raise the issue have been viciously attacked. A huge army of private interests is determined to keep the public enslaved to private insurers and high medical costs. The failure of our healthcare is in no small measure due to it being a fully for-profit operation. Last year, private health insurance accounted for 65 percent of coverage. Consider that there are over 900 private insurance companies in the US. National Health Expenditures (NHE) grew to $4.5 trillion in 2022, which was 17.3 percent of GDP. Older corporate rank-and-file Democrats and Republicans argue that a single-payer or socialized medical program is unaffordable. However, not only is single-payer affordable, it will end bankruptcies due to unpayable medical debt. In addition, universal healthcare, structured on a preventative model, will reduce disease rates at the outset. Corporate Democrats argue that Obama's Affordable Care Act (ACA) was a positive step inching the country towards complete public coverage. However, aside from providing coverage to the poorest of Americans, Obamacare turned into another financial anchor around the necks of millions more. According to the health policy research group KFF, the average annual health insurance premium for single coverage is $8,400 and almost $24,000 for a family. In addition, patient out-of-pocket costs continue to increase, a 6.6% increase to $471 billion in 2022. Rather than healthcare spending falling, it has exploded, and the Trump and Biden administrations made matters worse. Clearly, a universal healthcare program will require flipping the script on the entire private insurance industry, which employed over half a million people last year. Obviously, the most volatile debate concerning a national universal healthcare system concerns cost. Although there is already a socialized healthcare system in place -- every federal legislator, bureaucrat, government employee and veteran benefits from it -- fiscal Republican conservatives and groups such as the Koch Brothers network are single-mindedly dedicated to preventing the expansion of Medicare and Medicaid. A Koch-funded Mercatus analysis made the outrageous claim that a single-payer system would increase federal health spending by $32 trillion in ten years. However, analyses and reviews by the Congressional Budget Office in the early 1990s concluded that such a system would only increase spending at the start; enormous savings would quickly offset it as the years pass. In one analysis, "the savings in administrative costs [10 percent of health spending] would be more than enough to offset the expense of universal coverage." Defenders of those advocating for funding a National Health Program argue this can primarily be accomplished by raising taxes to levels comparable to other developed nations. This was a platform Senator Bernie Sanders and some of the younger progressive Democrats in the House campaigned on. The strategy was to tax the highest multimillion-dollar earners 60-70 percent. Despite the outrage of its critics, including old rank-and-file multi-millionaire Democrats like Nancy Pelosi and Chuck Schumer, this is still far less than in the past. During the Korean War, the top tax rate was 91 percent; it declined to 70 percent in the late 1960s. Throughout most of the 1970s, those in the lowest income bracket were taxed at 14 percent. We are not advocating for this strategy because it ignores where the funding is going, and the corruption in the system that is contributing to exorbitant waste. But Democratic supporters of the ACA who oppose a universal healthcare plan ignore the additional taxes Obama levied to pay for the program. These included surtaxes on investment income, Medicare taxes from those earning over $200,000, taxes on tanning services, an excise tax on medical equipment, and a 40 percent tax on health coverage for costs over the designated cap that applied to flexible savings and health savings accounts. The entire ACA was reckless, sloppy and unnecessarily complicated from the start. The fact that Obamacare further strengthened the distinctions between two parallel systems -- federal and private -- with entirely different economic structures created a labyrinth of red tape, rules, and wasteful bureaucracy. Since the ACA went into effect, over 150 new boards, agencies and programs have had to be established to monitor its 2,700 pages of gibberish. A federal single-payer system would easily eliminate this bureaucracy and waste. A medical New Deal to establish universal healthcare coverage is a decisive step in the correct direction. But we must look at the crisis holistically and in a systematic way. Simply shuffling private insurance into a federal Medicare-for-all or buy-in program, funded by taxing the wealthiest of citizens, would only temporarily reduce costs. It will neither curtail nor slash escalating disease rates e. Any effective healthcare reform must also tackle the underlying reasons for Americans' poor state of health. We cannot shy away from examining the social illnesses infecting our entire free-market capitalist culture and its addiction to deregulation. A viable healthcare model would have to structurally transform how the medical economy operates. Finally, a successful medical New Deal must honestly evaluate the best and most reliable scientific evidence in order to effectively redirect public health spending. For example, Dr. Ezekiel Emanuel, a former Obama healthcare adviser, observed that AIDS-HIV measures consume the most public health spending, even though the disease "ranked 75th on the list of diseases by personal health expenditures." On the other hand, according to the American Medical Association, a large percentage of the nation's $3.4 trillion healthcare spending goes towards treating preventable diseases, notably diabetes, common forms of heart disease, and back and neck pain conditions. In 2016, these three conditions were the most costly and accounted for approximately $277 billion in spending. Last year, the CDC announced the autism rate is now 1 in 36 children compared to 1 in 44 two years ago. A retracted study by Mark Blaxill, an autism activist at the Holland Center and a friend of the authors, estimates that ASD costs will reach $589 billion annually by 2030. There are no signs that this alarming trend will reverse and decline; and yet, our entire federal health system has failed to conscientiously investigate the underlying causes of this epidemic. All explanations that might interfere with the pharmaceutical industry's unchecked growth, such as over-vaccination, are ignored and viciously discredited without any sound scientific evidence. Therefore, a proper medical New Deal will require a systemic overhaul and reform of our federal health agencies, especially the HHS, CDC and FDA. Only the Robert Kennedy Jr presidential campaign is even addressing the crisis and has an inexpensive and comprehensive plan to deal with it. For any medical revolution to succeed in advancing universal healthcare, the plan must prioritize spending in a manner that serves public health and not private interests. It will also require reshuffling private corporate interests and their lobbyists to the sidelines, away from any strategic planning, in order to break up the private interests' control over federal agencies and its revolving door policies. Aside from those who benefit from this medical corruption, the overwhelming majority of Americans would agree with this criticism. However, there is a complete lack of national trust that our legislators, including the so-called progressives, would be willing to undertake such actions. In addition, America's healthcare system ignores the single most critical initiative to reduce costs - that is, preventative efforts and programs instead of deregulation and closing loopholes designed to protect the drug and insurance industries' bottom line. Prevention can begin with banning toxic chemicals that are proven health hazards associated with current disease epidemics, and it can begin by removing a 1,000-plus toxins already banned in Europe. This should be a no-brainer for any legislator who cares for public health. For example, Stacy Malkan, co-founder of the Campaign for Safe Cosmetics, notes that "the policy approach in the US and Europe is dramatically different" when it comes to chemical allowances in cosmetic products. Whereas the EU has banned 1,328 toxic substances from the cosmetic industry alone, the US has banned only 11. The US continues to allow carcinogenic formaldehyde, petroleum, forever chemicals, many parabens (an estrogen mimicker and endocrine hormone destroyer), the highly allergenic p-phenylenediamine or PBD, triclosan, which has been associated with the rise in antibiotic resistant bacteria, avobenzone, and many others to be used in cosmetics, sunscreens, shampoo and hair dyes. Next, the food Americans consume can be reevaluated for its health benefits. There should be no hesitation to tax the unhealthiest foods, such as commercial junk food, sodas and candy relying on high fructose corn syrup, products that contain ingredients proven to be toxic, and meat products laden with dangerous chemicals including growth hormones and antibiotics. The scientific evidence that the average American diet is contributing to rising disease trends is indisputable. We could also implement additional taxes on the public advertising of these demonstrably unhealthy products. All such tax revenue would accrue to a national universal health program to offset medical expenditures associated with the very illnesses linked to these products. Although such tax measures would help pay for a new medical New Deal, it may be combined with programs to educate the public about healthy nutrition if it is to produce a reduction in the most common preventable diseases. In fact, comprehensive nutrition courses in medical schools should be mandatory because the average physician receives no education in this crucial subject. In addition, preventative health education should be mandatory throughout public school systems. Private insurers force hospitals, clinics and private physicians into financial corners, and this is contributing to prodigious waste in money and resources. Annually, healthcare spending towards medical liability insurance costs tens of billions of dollars. In particular, this economic burden has taxed small clinics and physicians. It is well past the time that physician liability insurance is replaced with no-fault options. Today's doctors are spending an inordinate amount of money to protect themselves. Legions of liability and trial lawyers seek big paydays for themselves stemming from physician error. This has created a culture of fear among doctors and hospitals, resulting in the overly cautious practice of defensive medicine, driving up costs and insurance premiums just to avoid lawsuits. Doctors are forced to order unnecessary tests and prescribe more medications and medical procedures just to cover their backsides. No-fault insurance is a common-sense plan that enables physicians to pursue their profession in a manner that will reduce iatrogenic injuries and costs. Individual cases requiring additional medical intervention and loss of income would still be compensated. This would generate huge savings. No other nation suffers from the scourge of excessive drug price gouging like the US. After many years of haggling to lower prices and increase access to generic drugs, only a minute amount of progress has been made in recent years. A 60 Minutes feature about the Affordable Care Act reported an "orgy of lobbying and backroom deals in which just about everyone with a stake in the $3-trillion-a-year health industry came out ahead—except the taxpayers.” For example, Life Extension magazine reported that an antiviral cream (acyclovir), which had lost its patent protection, "was being sold to pharmacies for 7,500% over the active ingredient cost. The active ingredient (acyclovir) costs only 8 pennies, yet pharmacies are paying a generic maker $600 for this drug and selling it to consumers for around $700." Other examples include the antibiotic Doxycycline. The price per pill averages 7 cents to $3.36 but has a 5,300 percent markup when it reaches the consumer. The antidepressant Clomipramine is marked up 3,780 percent, and the anti-hypertensive drug Captopril's mark-up is 2,850 percent. And these are generic drugs! Medication costs need to be dramatically cut to allow drug manufacturers a reasonable but not obscene profit margin. By capping profits approximately 100 percent above all costs, we would save our system hundreds of billions of dollars. Such a measure would also extirpate the growing corporate misdemeanors of pricing fraud, which forces patients to pay out-of-pocket in order to make up for the costs insurers are unwilling to pay. Finally, we can acknowledge that our healthcare is fundamentally a despotic rationing system based upon high insurance costs vis-a-vis a toss of the dice to determine where a person sits on the economic ladder. For the past three decades it has contributed to inequality. The present insurance-based economic metrics cast millions of Americans out of coverage because private insurance costs are beyond their means. Uwe Reinhardt, a Princeton University political economist, has called our system "brutal" because it "rations [people] out of the system." He defined rationing as "withholding something from someone that is beneficial." Discriminatory healthcare rationing now affects upwards to 60 million people who have been either priced out of the system or under insured. They make too much to qualify for Medicare under Obamacare, yet earn far too little to afford private insurance costs and premiums. In the final analysis, the entire system is discriminatory and predatory. However, we must be realistic. Almost every member of Congress has benefited from Big Pharma and private insurance lobbyists. The only way to begin to bring our healthcare program up to the level of a truly developed nation is to remove the drug industry's rampant and unnecessary profiteering from the equation. How did Fauci memory-hole a cure for AIDS and get away with it? By Helen Buyniski Over 700,000 Americans have died of AIDS since 1981, with the disease claiming some 42.3 million victims worldwide. While an HIV diagnosis is no longer considered a certain death sentence, the disease looms large in the public imagination and in public health funding, with contemporary treatments running into thousands of dollars per patient annually. But was there a cure for AIDS all this time - an affordable and safe treatment that was ruthlessly suppressed and attacked by the US public health bureaucracy and its agents? Could this have saved millions of lives and billions of dollars spent on AZT, ddI and failed HIV vaccine trials? What could possibly justify the decision to disappear a safe and effective approach down the memory hole? The inventor of the cure, Gary Null, already had several decades of experience creating healing protocols for physicians to help patients not responding well to conventional treatments by the time AIDS was officially defined in 1981. Null, a registered dietitian and board-certified nutritionist with a PhD in human nutrition and public health science, was a senior research fellow and Director of Anti-Aging Medicine at the Institute of Applied Biology for 36 years and has published over 950 papers, conducting groundbreaking experiments in reversing biological aging as confirmed with DNA methylation testing. Additionally, Null is a multi-award-winning documentary filmmaker, bestselling author, and investigative journalist whose work exposing crimes against humanity over the last 50 years has highlighted abuses by Big Pharma, the military-industrial complex, the financial industry, and the permanent government stay-behind networks that have come to be known as the Deep State. Null was contacted in 1974 by Dr. Stephen Caiazza, a physician working with a subculture of gay men in New York living the so-called “fast track” lifestyle, an extreme manifestation of the gay liberation movement that began with the Stonewall riots. Defined by rampant sexual promiscuity and copious use of illegal and prescription drugs, including heavy antibiotic use for a cornucopia of sexually-transmitted diseases, the fast-track never included more than about two percent of gay men, though these dominated many of the bathhouses and clubs that defined gay nightlife in the era. These patients had become seriously ill as a result of their indulgence, generally arriving at the clinic with multiple STDs including cytomegalovirus and several types of herpes and hepatitis, along with candida overgrowth, nutritional deficiencies, gut issues, and recurring pneumonia. Every week for the next 10 years, Null would counsel two or three of these men - a total of 800 patients - on how to detoxify their bodies and de-stress their lives, tracking their progress with Caiazza and the other providers at weekly feedback meetings that he credits with allowing the team to quickly evaluate which treatments were most effective. He observed that it only took about two years on the “fast track” for a healthy young person to begin seeing muscle loss and the recurrent, lingering opportunistic infections that would later come to be associated with AIDS - while those willing to commit to a healthier lifestyle could regain their health in about a year. It was with this background that Null established the Tri-State Healing Center in Manhattan in 1980, staffing the facility with what would eventually run to 22 certified health professionals to offer safe, natural, and effective low- and no-cost treatments to thousands of patients with HIV and AIDS-defining conditions. Null and his staff used variations of the protocols he had perfected with Caiazza's patients, a multifactorial patient-tailored approach that included high-dose vitamin C drips, intravenous ozone therapy, juicing and nutritional improvements and supplementation, aspects of homeopathy and naturopathy with some Traditional Chinese Medicine and Ayurvedic practices. Additional services offered on-site included acupuncture and holistic dentistry, while peer support groups were also held at the facility so that patients could find community and a positive environment, healing their minds and spirits while they healed their bodies. “Instead of trying to kill the virus with antiretroviral pharmaceuticals designed to stop viral replication before it kills patients, we focused on what benefits could be gained by building up the patients' natural immunity and restoring biochemical integrity so the body could fight for itself,” Null wrote in a 2014 article describing the philosophy behind the Center's approach, which was wholly at odds with the pharmaceutical model.1 Patients were comprehensively tested every week, with any “recovery” defined solely by the labs, which documented AIDS patient after patient - 1,200 of them - returning to good health and reversing their debilitating conditions. Null claims to have never lost an AIDS patient in the Center's care, even as the death toll for the disease - and its pharmaceutical standard of care AZT - reached an all-time high in the early 1990s. Eight patients who had opted for a more intensive course of treatment - visiting the Center six days a week rather than one - actually sero-deconverted, with repeated subsequent testing showing no trace of HIV in their bodies. As an experienced clinical researcher himself, Null recognized that any claims made by the Center would be massively scrutinized, challenging as they did the prevailing scientific consensus that AIDS was an incurable, terminal illness. He freely gave his protocols to any medical practitioner who asked, understanding that his own work could be considered scientifically valid only if others could replicate it under the same conditions. After weeks of daily observational visits to the Center, Dr. Robert Cathcart took the protocols back to San Francisco, where he excitedly reported that patients were no longer dying in his care. Null's own colleague at the Institute of Applied Biology, senior research fellow Elana Avram, set up IV drip rooms at the Institute and used his intensive protocols to sero-deconvert 10 patients over a two-year period. While the experiment had been conducted in secret, as the Institute had been funded by Big Pharma since its inception half a century earlier, Avram had hoped she would be able to publish a journal article to further publicize Null's protocols and potentially help AIDS patients, who were still dying at incredibly high rates thanks to Burroughs Wellcome's noxious but profitable AZT. But as she would later explain in a 2019 letter to Null, their groundbreaking research never made it into print - despite meticulous documentation of their successes - because the Institute's director and board feared their pharmaceutical benefactors would withdraw the funding on which they depended, given that Null's protocols did not involve any patentable or otherwise profitable drugs. When Avram approached them about publication, the board vetoed the idea, arguing that it would “draw negative attention because [the work] was contrary to standard drug treatments.” With no real point in continuing experiments along those lines without institutional support and no hope of obtaining funding from elsewhere, the department she had created specifically for these experiments shut down after a two-year followup with her test subjects - all of whom remained alive and healthy - was completed.2 While the Center was receiving regular visits by this time from medical professionals and, increasingly, black celebrities like Stokely Carmichael and Isaac Hayes, who would occasionally perform for the patients, the news was spreading by word of mouth alone - not a single media outlet had dared to document the clinic that was curing AIDS patients for free. Instead, they gave airtime to Anthony Fauci, director of the National Institute of Allergies and Infectious Diseases, who had for years been spreading baseless, hysteria-fueling claims about HIV and AIDS to any news outlet that would put him on. His claim that children could contract the virus from “ordinary household conduct” with an infected relative proved so outrageous he had to walk it back,3 and he never really stopped insisting the deadly plague associated with gays and drug users was about to explode like a nuclear bomb among the law-abiding heterosexual population. Fauci by this time controlled all government science funding through NIAID, and his zero-tolerance approach to dissent on the HIV/AIDS front had already seen prominent scientists like virologist Peter Duesberg stripped of the resources they needed for their work because they had dared to question his commandment: There is no cause of AIDS but HIV, and AZT is its treatment. Even the AIDS activist groups, which by then had been coopted by Big Pharma and essentially reduced to astroturfing for the toxic failed chemotherapy drug AZT backed by the institutional might of Fauci's NIAID,4 didn't seem to want to hear that there was a cure. Unconcerned with the irrationality of denouncing the man touting his free AIDS cure as an “AIDS denier,” they warned journalists that platforming Null or anyone else rejecting the mainstream medical line would be met with organized demands for their firing. Determined to breach the institutional iron curtain and get his message to the masses, Null and his team staged a press conference in New York, inviting scientists and doctors from around the world to share their research on alternative approaches to HIV and AIDS in 1993. To emphasize the sound scientific basis of the Center's protocols and encourage guests to adopt them into their own practices, Null printed out thousands of abstracts in support of each nutrient and treatment being used. However, despite over 7,000 invitations sent three times to major media, government figures, scientists, and activists, almost none of the intended audience members showed up. Over 100 AIDS patients and their doctors, whose charts exhaustively documented their improvements using natural and nontoxic modalities over the preceding 12 months, gave filmed testimonials, declaring that the feared disease was no longer a death sentence, but the conference had effectively been silenced. Bill Tatum, publisher of the Amsterdam News, suggested Null and his patients would find a more welcoming audience in his home neighborhood of Harlem - specifically, its iconic Apollo Theatre. For three nights, the theater was packed to capacity. Hit especially hard by the epidemic and distrustful of a medical system that had only recently stopped being openly racist (the Tuskegee syphilis experiment only ended in 1972), black Americans, at least, did not seem to care what Anthony Fauci would do if he found out they were investigating alternatives to AZT and death. PBS journalist Tony Brown, having obtained a copy of the video of patient testimonials from the failed press conference, was among a handful of black journalists who began visiting the Center to investigate the legitimacy of Null's claims. Satisfied they had something significant to offer his audience, Brown invited eight patients - along with Null himself - onto his program over the course of several episodes to discuss the work. It was the first time these protocols had received any attention in the media, despite Null having released nearly two dozen articles and multiple documentaries on the subject by that time. A typical patient on one program, Al, a recovered IV drug user who was diagnosed with AIDS at age 32, described how he “panicked,” saw a doctor and started taking AZT despite his misgivings - only to be forced to discontinue the drug after just a few weeks due to his condition deteriorating rapidly. Researching alternatives brought him to Null, and after six months of “detoxing [his] lifestyle,” he observed his initial symptoms - swollen lymph nodes and weight loss - begin to reverse, culminating with sero-deconversion. On Bill McCreary's Channel 5 program, a married couple diagnosed with HIV described how they watched their T-cell counts increase as they cut out sugar, caffeine, smoking, and drinking and began eating a healthy diet. They also saw the virus leave their bodies. For HIV-positive viewers surrounded by fear and negativity, watching healthy-looking, cheerful “AIDS patients” detail their recovery while Null backed up their claims with charts must have been balm for the soul. But the TV programs were also a form of outreach to the medical community, with patients' charts always on hand to convince skeptics the cure was scientifically valid. Null brought patients' charts to every program, urging them to keep an open mind: “Other physicians and public health officials should know that there's good science in the alternative perspective. It may not be a therapy that they're familiar with, because they're just not trained in it, but if the results are positive, and you can document them…” He challenged doubters to send in charts from their own sero-deconverted patients on AZT, and volunteered to debate proponents of the orthodox treatment paradigm - though the NIH and WHO both refused to participate in such a debate on Tony Brown's Journal, following Fauci's directive prohibiting engagement with forbidden ideas. Aside from those few TV programs and Null's own films, suppression of Null's AIDS cure beyond word of mouth was total. The 2021 documentary The Cost of Denial, produced by the Society for Independent Journalists, tells the story of the Tri-State Healing Center and the medical paradigm that sought to destroy it, lamenting the loss of the lives that might have been saved in a more enlightened society. Nurse practitioner Luanne Pennesi, who treated many of the AIDS patients at the Center, speculated in the film that the refusal by the scientific establishment and AIDS activists to accept their successes was financially motivated. “It was as if they didn't want this information to get out. Understand that our healthcare system as we know it is a corporation, it's a corporate model, and it's about generating revenue. My concern was that maybe they couldn't generate enough revenue from these natural approaches.”5 Funding was certainly the main disciplinary tool Fauci's NIAID used to keep the scientific community in line. Despite the massive community interest in the work being done at the Center, no foundation or institution would defy Fauci and risk getting itself blacklisted, leaving Null to continue funding the operation out of his pocket with the profits from book sales. After 15 years, he left the Center in 1995, convinced the mainstream model had so thoroughly been institutionalized that there was no chance of overthrowing it. He has continued to counsel patients and advocate for a reappraisal of the HIV=AIDS hypothesis and its pharmaceutical treatments, highlighting the deeply flawed science underpinning the model of the disease espoused by the scientific establishment in 39 articles, six documentaries and a 700-page textbook on AIDS, but the Center's achievements have been effectively memory-holed by Fauci's multi-billion-dollar propaganda apparatus. FRUIT OF THE POISONOUS TREE To understand just how much of a threat Null's work was to the HIV/AIDS establishment, it is instructive to revisit the 1984 paper, published by Dr. Robert Gallo of the National Cancer Institute, that established HIV as the sole cause of AIDS. The CDC's official recognition of AIDS in 1981 had done little to quell the mounting public panic over the mysterious illness afflicting gay men in the US, as the agency had effectively admitted it had no idea what was causing them to sicken and die. As years passed with no progress determining the causative agent of the plague, activist groups like Gay Men's Health Crisis disrupted public events and threatened further mass civil disobedience as they excoriated the NIH for its sluggish allocation of government science funding to uncovering the cause of the “gay cancer.”6 When Gallo published his paper declaring that the retrovirus we now know as HIV was the sole “probable” cause of AIDS, its simple, single-factor hypothesis was the answer to the scientific establishment's prayers. This was particularly true for Fauci, as the NIAID chief was able to claim the hot new disease as his agency's own domain in what has been described as a “dramatic confrontation” with his rival Sam Broder at the National Cancer Institute. After all, Fauci pointed out, Gallo's findings - presented by Health and Human Services Secretary Margaret Heckler as if they were gospel truth before any other scientists had had a chance to inspect them, never mind conduct a full peer review - clearly classified AIDS as an infectious disease, and not a cancer like the Kaposi's sarcoma which was at the time its most visible manifestation. Money and media attention began pouring in, even as funding for the investigation of other potential causes of AIDS dried up. Having already patented a diagnostic test for “his” retrovirus before introducing it to the world, Gallo was poised for a financial windfall, while Fauci was busily leveraging the discovery into full bureaucratic empire of the US scientific apparatus. While it would serve as the sole basis for all US government-backed AIDS research to follow - quickly turning Gallo into the most-cited scientist in the world during the 1980s,7 Gallo's “discovery” of HIV was deeply problematic. The sample that yielded the momentous discovery actually belonged to Prof. Luc Montagnier of the French Institut Pasteur, a fact Gallo finally admitted in 1991, four years after a lawsuit from the French government challenged his patent on the HIV antibody test, forcing the US government to negotiate a hasty profit-sharing agreement between Gallo's and Montagnier's labs. That lawsuit triggered a cascade of official investigations into scientific misconduct by Gallo, and evidence submitted during one of these probes, unearthed in 2008 by journalist Janine Roberts, revealed a much deeper problem with the seminal “discovery.” While Gallo's co-author, Mikulas Popovic, had concluded after numerous experiments with the French samples that the virus they contained was not the cause of AIDS, Gallo had drastically altered the paper's conclusion, scribbling his notes in the margins, and submitted it for publication to the journal Science without informing his co-author. After Roberts shared her discovery with contacts in the scientific community, 37 scientific experts wrote to the journal demanding that Gallo's career-defining HIV paper be retracted from Science for lacking scientific integrity.8 Their call, backed by an endorsement from the 2,600-member scientific organization Rethinking AIDS, was ignored by the publication and by the rest of mainstream science despite - or perhaps because of - its profound implications. That 2008 letter, addressed to Science editor-in-chief Bruce Alberts and copied to American Association for the Advancement of Science CEO Alan Leshner, is worth reproducing here in its entirety, as it utterly dismantles Gallo's hypothesis - and with them the entire HIV is the sole cause of AIDS dogma upon which the contemporary medical model of the disease rests: On May 4, 1984 your journal published four papers by a group led by Dr. Robert Gallo. We are writing to express our serious concerns with regard to the integrity and veracity of the lead paper among these four of which Dr. Mikulas Popovic is the lead author.[1] The other three are also of concern because they rely upon the conclusions of the lead paper .[2][3][4] In the early 1990s, several highly critical reports on the research underlying these papers were produced as a result of governmental inquiries working under the supervision of scientists nominated by the National Academy of Sciences and the Institute of Medicine. The Office of Research Integrity of the US Department of Health and Human Services concluded that the lead paper was “fraught with false and erroneous statements,” and that the “ORI believes that the careless and unacceptable keeping of research records...reflects irresponsible laboratory management that has permanently impaired the ability to retrace the important steps taken.”[5] Further, a Congressional Subcommittee on Oversight and Investigations led by US Representative John D. Dingell of Michigan produced a staff report on the papers which contains scathing criticisms of their integrity.[6] Despite the publically available record of challenges to their veracity, these papers have remained uncorrected and continue to be part of the scientific record. What prompts our communication today is the recent revelation of an astonishing number of previously unreported deletions and unjustified alterations made by Gallo to the lead paper. There are several documents originating from Gallo's laboratory that, while available for some time, have only recently been fully analyzed. These include a draft of the lead paper typewritten by Popovic which contains handwritten changes made to it by Gallo.[7] This draft was the key evidence used in the above described inquiries to establish that Gallo had concealed his laboratory's use of a cell culture sample (known as LAV) which it received from the Institut Pasteur. These earlier inquiries verified that the typed manuscript draft was produced by Popovic who had carried out the recorded experiment while his laboratory chief, Gallo, was in Europe and that, upon his return, Gallo changed the document by hand a few days before it was submitted to Science on March 30, 1984. According to the ORI investigation, “Dr. Gallo systematically rewrote the manuscript for what would become a renowned LTCB [Gallo's laboratory at the National Cancer Institute] paper.”[5] This document provided the important evidence that established the basis for awarding Dr. Luc Montagnier and Dr. Francoise Barré-Sinoussi the 2008 Nobel Prize in Medicine for the discovery of the AIDS virus by proving it was their samples of LAV that Popovic used in his key experiment. The draft reveals that Popovic had forthrightly admitted using the French samples of LAV renamed as Gallo's virus, HTLV-III, and that Gallo had deleted this admission, concealing their use of LAV. However, it has not been previously reported that on page three of this same document Gallo had also deleted Popovic's unambiguous statement that, "Despite intensive research efforts, the causative agent of AIDS has not yet been identified,” replacing it in the published paper with a statement that said practically the opposite, namely, “That a retrovirus of the HTLV family might be an etiologic agent of AIDS was suggested by the findings.” It is clear that the rest of Popovic's typed paper is entirely consistent with his statement that the cause of AIDS had not been found, despite his use of the French LAV. Popovic's final conclusion was that the culture he produced “provides the possibility” for detailed studies. He claimed to have achieved nothing more. At no point in his paper did Popovic attempt to prove that any virus caused AIDS, and it is evident that Gallo concealed these key elements in Popovic's experimental findings. It is astonishing now to discover these unreported changes to such a seminal document. We can only assume that Gallo's alterations of Popovic's conclusions were not highlighted by earlier inquiries because the focus at the time was on establishing that the sample used by Gallo's lab came from Montagnier and was not independently collected by Gallo. In fact, the only attention paid to the deletions made by Gallo pertains to his effort to hide the identity of the sample. The questions of whether Gallo and Popovic's research proved that LAV or any other virus was the cause of AIDS were clearly not considered. Related to these questions are other long overlooked documents that merit your attention. One of these is a letter from Dr. Matthew A. Gonda, then Head of the Electron Microscopy Laboratory at the National Cancer Institute, which is addressed to Popovic, copied to Gallo and dated just four days prior to Gallo's submission to Science.[8] In this letter, Gonda remarks on samples he had been sent for imaging because “Dr Gallo wanted these micrographs for publication because they contain HTLV.” He states, “I do not believe any of the particles photographed are of HTLV-I, II or III.” According to Gonda, one sample contained cellular debris, while another had no particles near the size of a retrovirus. Despite Gonda's clearly worded statement, Science published on May 4, 1984 papers attributed to Gallo et al with micrographs attributed to Gonda and described unequivocally as HTLV-III. In another letter by Gallo, dated one day before he submitted his papers to Science, Gallo states, “It's extremely rare to find fresh cells [from AIDS patients] expressing the virus... cell culture seems to be necessary to induce virus,” a statement which raises the possibility he was working with a laboratory artifact. [9] Included here are copies of these documents and links to the same. The very serious flaws they reveal in the preparation of the lead paper published in your journal in 1984 prompts our request that this paper be withdrawn. It appears that key experimental findings have been concealed. We further request that the three associated papers published on the same date also be withdrawn as they depend on the accuracy of this paper. For the scientific record to be reliable, it is vital that papers shown to be flawed, or falsified be retracted. Because a very public record now exists showing that the Gallo papers drew unjustified conclusions, their withdrawal from Science is all the more important to maintain integrity. Future researchers must also understand they cannot rely on the 1984 Gallo papers for statements about HIV and AIDS, and all authors of papers that previously relied on this set of four papers should have the opportunity to consider whether their own conclusions are weakened by these revelations. Gallo's handwritten revision, submitted without his colleague's knowledge despite multiple experiments that failed to support the new conclusion, was the sole foundation for the HIV=AIDS hypothesis. Had Science published the manuscript the way Popovic had typed it, there would be no AIDS “pandemic” - merely small clusters of people with AIDS. Without a viral hypothesis backing the development of expensive and deadly pharmaceuticals, would Fauci have allowed these patients to learn about the cure that existed all along? Faced with a potential rebellion, Fauci marshaled the full resources under his control to squelch the publication of the investigations into Gallo and restrict any discussion of competing hypotheses in the scientific and mainstream press, which had been running virus-scare stories full-time since 1984. The effect was total, according to biochemist Dr. Kary Mullis, inventor of the polymerase chain reaction (PCR) procedure. In a 2009 interview, Mullis recalled his own shock when he attempted to unearth the experimental basis for the HIV=AIDS hypothesis. Despite his extensive inquiry into the literature, “there wasn't a scientific reference…[that] said ‘here's how come we know that HIV is the probable cause of AIDS.' There was nothing out there like that.”9 This yawning void at the core of HIV/AIDS “science" turned him into a strident critic of AIDS dogma - and those views made him persona non grata where the scientific press was concerned, suddenly unable to publish a single paper despite having won the Nobel Prize for his invention of the PCR test just weeks before. 10 DISSENT BECOMES “DENIAL” While many of those who dissent from the orthodox HIV=AIDS view believe HIV plays a role in the development of AIDS, they point to lifestyle and other co-factors as being equally if not more important. Individuals who test positive for HIV can live for decades in perfect health - so long as they don't take AZT or the other toxic antivirals fast-tracked by Fauci's NIAID - but those who developed full-blown AIDS generally engaged in highly risky behaviors like extreme promiscuity and prodigious drug abuse, contracting STDs they took large quantities of antibiotics to treat, further running down their immune systems. While AIDS was largely portrayed as a “gay disease,” it was only the “fast track” gays, hooking up with dozens of partners nightly in sex marathons fueled by “poppers” (nitrate inhalants notorious for their own devastating effects on the immune system), who became sick. Kaposi's sarcoma, one of the original AIDS-defining conditions, was widespread among poppers-using gay men, but never appeared among IV drug users or hemophiliacs, the other two main risk groups during the early years of the epidemic. Even Robert Gallo himself, at a 1994 conference on poppers held by the National Institute on Drug Abuse, would admit that the previously-rare form of skin cancer surging among gay men was not primarily caused by HIV - and that it was immune stimulation, rather than suppression, that was likely responsible.11 Similarly, IV drug users are often riddled with opportunistic infections as their habit depresses the immune system and their focus on maintaining their addiction means that healthier habits - like good nutrition and even basic hygiene - fall by the wayside. Supporting the call for revising the HIV=AIDS hypothesis to include co-factors is the fact that the mass heterosexual outbreaks long predicted by Fauci and his ilk in seemingly every country on Earth have failed to materialize, except - supposedly - in Africa, where the diagnostic standard for AIDS differs dramatically from those of the West. Given the prohibitively high cost of HIV testing for poor African nations, the WHO in 1985 crafted a diagnostic loophole that became known as the “Bangui definition,” allowing medical professionals to diagnose AIDS in the absence of a test using just clinical symptoms: high fever, persistent cough, at least 30 days of diarrhea, and the loss of 10% of one's body weight within two months. Often suffering from malnutrition and without access to clean drinking water, many of the inhabitants of sub-Saharan Africa fit the bill, especially when the WHO added tuberculosis to the list of AIDS-defining illnesses in 1993 - a move which may be responsible for as many as one half of African “AIDS” cases, according to journalist Christine Johnson. The WHO's former Chief of Global HIV Surveillance, James Chin, acknowledged their manipulation of statistics, but stressed that it was the entire AIDS industry - not just his organization - perpetrating the fraud. “There's the saying that, if you knew what sausages are made of, most people would hesitate to sort of eat them, because they wouldn't like what's in it. And if you knew how HIV/AIDS numbers are cooked, or made up, you would use them with extreme caution,” Chin told an interviewer in 2009.12 With infected numbers stubbornly remaining constant in the US despite Fauci's fearmongering projections of the looming heterosexually-transmitted plague, the CDC in 1993 broadened its definition of AIDS to include asymptomatic (that is, healthy) HIV-positive people with low T-cell counts - an absurd criteria given that an individual's T-cell count can fluctuate by hundreds within a single day. As a result, the number of “AIDS cases” in the US immediately doubled. Supervised by Fauci, the NIAID had been quietly piling on diseases into the “AIDS-related” category for years, bloating the list from just two conditions - pneumocystis carinii pneumonia and Kaposi's sarcoma - to 30 so fast it raised eyebrows among some of science's leading lights. Deeming the entire process “bizarre” and unprecedented, Kary Mullis wondered aloud why no one had called the AIDS establishment out: “There's something wrong here. And it's got to be financial.”13 Indeed, an early CDC public relations campaign was exposed by the Wall Street Journal in 1987 as having deliberately mischaracterized AIDS as a threat to the entire population so as to garner increased public and private funding for what was very much a niche issue, with the risk to average heterosexuals from a single act of sex “smaller than the risk of ever getting hit by lightning.” Ironically, the ads, which sought to humanize AIDS patients in an era when few Americans knew anyone with the disease and more than half the adult population thought infected people should be forced to carry cards warning of their status, could be seen as a reaction to the fear tactics deployed by Fauci early on.14 It's hard to tell where fraud ends and incompetence begins with Gallo's HIV antibody test. Much like Covid-19 would become a “pandemic of testing,” with murder victims and motorcycle crashes lumped into “Covid deaths” thanks to over-sensitized PCR tests that yielded as many as 90% false positives,15 HIV testing is fraught with false positives - and unlike with Covid-19, most people who hear they are HIV-positive still believe they are receiving a death sentence. Due to the difficulty of isolating HIV itself from human samples, the most common diagnostic tests, ELISA and the Western Blot, are designed to detect not the virus but antibodies to it, upending the traditional medical understanding that the presence of antibodies indicates only exposure - and often that the body has actually vanquished the pathogen. Patients are known to test positive for HIV antibodies in the absence of the virus due to at least 70 other conditions, including hepatitis, lupus, rheumatoid arthritis, syphilis, recent vaccination or even pregnancy. (https://www.chcfl.org/diseases-that-can-cause-a-false-positive-hiv-test/) Positive results are often followed up with a PCR “viral load” test, even though the inventor of the PCR technique Kary Mullis famously condemned its misuse as a tool for diagnosing infection. Packaging inserts for all three tests warn the user that they cannot be reliably used to diagnose HIV.16 The ELISA HIV antibody test explicitly states: “At present there is no recognized standard for establishing the presence and absence of HIV antibody in human blood.”17 That the public remains largely unaware of these and other massive holes in the supposedly airtight HIV=AIDS=DEATH paradigm is a testament to Fauci's multi-layered control of the press. Like the writers of the Great Barrington Declaration and other Covid-19 dissidents, scientists who question HIV/AIDS dogma have been brutally punished for their heresy, no matter how prestigious their prior standing in the field and no matter how much evidence they have for their own claims. In 1987, the year the FDA's approval of AZT made AIDS the most profitable epidemic yet (a dubious designation Covid-19 has since surpassed), Fauci made it clearer than ever that scientific inquiry and debate - the basis of the scientific method - would no longer be welcome in the American public health sector, eliminating retrovirologist Peter Duesberg, then one of the most prominent opponents of the HIV=AIDS hypothesis, from the scientific conversation with a professional disemboweling that would make a cartel hitman blush. Duesberg had just eviscerated Gallo's 1984 HIV paper with an article of his own in the journal Cancer Research, pointing out that retroviruses had never before been found to cause a single disease in humans - let alone 30 AIDS-defining diseases. Rather than allow Gallo or any of the other scientists in his camp to respond to the challenge, Fauci waged a scorched-earth campaign against Duesberg, who had until then been one of the most highly regarded researchers in his field. Every research grant he requested was denied; every media appearance was canceled or preempted. The University of California at Berkeley, unable to fully fire him due to tenure, took away his lab, his graduate students, and the rest of his funding. The few colleagues who dared speak up for him in public were also attacked, while enemies and opportunists were encouraged to slander Duesberg at the conferences he was barred from attending and in the journals that would no longer publish his replies. When Duesberg was summoned to the White House later that year by then-President Ronald Reagan to debate Fauci on the origins of AIDS, Fauci convinced the president to cancel, allegedly pulling rank on the Commander-in-Chief with an accusation that the “White House was interfering in scientific matters that belonged to the NIH and the Office of Science and Technology Assessment.” After seven years of this treatment, Duesberg was contacted by NIH official Stephen O'Brien and offered an escape from professional purgatory. He could have “everything back,” he was told, and shown a manuscript of a scientific paper - apparently commissioned by the editor of the journal Nature - “HIV Causes AIDS: Koch's Postulates Fulfilled” with his own name listed alongside O'Brien's as an author.18 His refusal to take the bribe effectively guaranteed the epithet “AIDS denier” will appear on his tombstone. The character assassination of Duesberg became a template that would be deployed to great effectiveness wherever Fauci encountered dissent - never debate, only demonize, deplatform and destroy. Even Luc Montagnier, the real discoverer of HIV, soon found himself on the wrong side of the Fauci machine. With his 1990 declaration that “the HIV virus [by itself] is harmless and passive, a benign virus,” Montagnier began distancing himself from Gallo's fraud, effectively placing a target on his own back. In a 1995 interview, he elaborated: “four factors that have come together to account for the sudden epidemic [of AIDS]: HIV presence, immune hyper-activation, increased sexually transmitted disease incidence, sexual behavior changes and other behavioral changes” such as drug use, poor nutrition and stress - all of which he said had to occur “essentially simultaneously” for HIV to be transmitted, creating the modern epidemic. Like the professionals at the Tri-State Healing Center, Montagnier advocated for the use of antioxidants like vitamin C and N-acetyl cysteine, naming oxidative stress as a critical factor in the progression from HIV to AIDS.19 When Montagnier died in 2022, Fauci's media mouthpieces sneered that the scientist (who was awarded the Nobel Prize in 2008 for his discovery of HIV, despite his flagging faith in that discovery's significance) “started espousing views devoid of a scientific basis” in the late 2000s, leading him to be “shunned by the scientific community.”20 In a particularly egregious jab, the Washington Post's obit sings the praises of Robert Gallo, implying it was the American scientist who really should have won the Nobel for HIV, while dismissing as “
In this month's Deals Deals Deals podcast, we welcome back David France who was last on episode 175 on 1st October 2023, to go through how he uses auctions within his business. Dave is based in the Lake District and was previously a joiner before getting involved in property sourcing. He is now in his 2nd year on Property Entrepreneur Advanced and has used the Blueprints to systematise his business so that he can focus on working on the high value activities he enjoys. Dave has four businesses, a sourcing company, a training company helping people to source property, his property portfolio and the auction business. We discuss four of the deals they have just sold within auction, how they found the deals, the location and types of properties and the reasons why they were being sold in auction. There was also a deal they had bought for cash and sold in a London auction through insurance bidding. The numbers: West Sussex 4 bed detached, sold at £665k with £40k fee London 2 bed flat that had failed to sell with national company, sold £380k with £21k fee Oxford 3 bed HMO with title issues sold for £230k with £20k fee A property they bought for £95k and sold immediately to an insurance bidder for £125k Combined fees of £111k Want to contact Mark or his guests? www.thepropertybrokerage.co.uk mark@thepropertybrokerage.co.uk David France david@fastpropertypartners.com
The Plant Free MD with Dr Anthony Chaffee: A Carnivore Podcast
In this revelatory episode, I am joined by Dr. Don, a seasoned physician with four decades of experience, hailing from California. Over the course of his distinguished career, he has witnessed firsthand the profound harm wrought by the rise of centralized medicine—harm that, tragically, he himself contributed to through his involvement with a large HMO in the state. Now, with a deepened awareness of the devastating impact this system has had on countless patients, Dr. Don has dedicated himself to righting these wrongs. His mission is nothing less than to undo the damage done and prevent further suffering. As part of his crusade, he is exploring the possibility of a class action lawsuit against these powerful HMOs for their decades-long history of malpractice, neglect, and the dissemination of false information. Join us for an engaging and meticulously detailed conversation, in which Dr. Don offers a sobering critique of the current medical landscape. His insights are not only a call to action but also an invitation to consider what we, as individuals and as a society, can do to transform a system that has long been broken. Don't miss this compelling and thought-provoking discussion—one that may well inspire you to become an agent of change within the healthcare system. Don't forget to like and subscribe to the Plant Free MD channel for more informative and inspiring content! ✅ Dr Chaffee's website: www.thecarnivorelife.com ✅Join my PATREON for early releases, bonus content, and weekly Zoom meetings! https://www.patreon.com/AnthonyChaffeeMD ✅Sign up for our 30-day carnivore challenge and group here! https://www.howtocarnivore.com/ ✅Stockman Steaks, Australia Discount link for home delivered frozen grass-fed and grass finished pasture raised meat locally sourced here in Australia! Use discount code "CHAFFEE" for free gift with qualifying orders! http://www.stockmansteaks.com.au/chaffee ✅ 60-minute consultation with Dr Chaffee https://calendly.com/anthonychaffeemd/60-minute-consultation Sponsors and Affiliates: ✅ Brand Ambassador for Stone and Spear tallow and soaps referral link https://www.stoneandspeartallow.com/?ref=gx0gql8b Discount Code "CHAFFEE" for 10% off ✅ Carnivore t-shirts from the Plant Free MD www.plantfreetees.com ✅THE CARNIVORE BAR: Discount Code "Anthony" for 10% off all orders! https://the-carnivore-bar.myshopify.com/?sca_ref=1743809.v3IrTuyDIi ✅Schwank Grill (Natural Gas or Propane) https://glnk.io/503n/anthonychaffeemd $150 OFF with Discount Code: ANTHONYMD ✅X3 bar system with discount code "DRCHAFFEE" https://www.kqzyfj.com/click-100676052-13511487 ✅Cerule Stem cells https://DrChaffee.cerule.com ✅CARNIVORE CRISPS: Discount Code "DRCHAFFEEMD" for 10% off all orders! www.carnivorecrisps.com ✅Shop Amazon https://www.amazon.com/shop/anthonychaffeemd?ref=ac_inf_hm_vp And please like and subscribe to my podcast here and Apple/Google podcasts, as well as my YouTube Channel to get updates on all new content, and please consider giving a 5-star rating as it really helps! This podcast is for general informational purposes only and does not constitute the practice of medicine, nursing or other professional health care services, including the giving of medical advice, and no doctor/patient relationship is formed. The use of information on this podcast or materials linked from this podcast is at the user's own risk. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Users should not disregard or delay in obtaining medical advice for any medical condition they may have and should seek the assistance of their health care professionals for any such conditions. Music Credit: Music by: bensound.com License code: MPTEUCI8DAXJOKPZ Music: bensound.com License code: FJQPPMCJLHEOYGQB Music: Bensound.com/royalty-free-music License code: KQAKMWSXIH3MJ4WX Music I use: https://www.bensound.com License code: 58NN4QOSKWJ7ASX9
© 2020-2025 Ivy Podcast Discovery LLC
